SUBJECT INDEX VOLUME 105 (JANUARY-JUNE, 1994)

Warner, Angeline E., 50S Wasserman, Karlman, 1693 Wassermann, Klaus, 1324 Watanabe, Masazumi, 856 Watkins, R, 785 Watling, Sharon, 1915 Watson, Richard Mo , 1434 Watson, Wade T. , 1439 Watt, Janet L., 1370 Watts, Rodney Eo, 183 Weaver, Lindell K, 1270 Weber, n. W o, 117 Webster, Robert 0 ., 1015 Weder, Walter, 1871 Wegman, David H., 1713 Wegner, Robert E., 1632 Wehner, John H; 1770 Wei, Richard, 853 Weiland, Jeffrey E., 1855 Weiman, Darryl So, 1454 Weiner, Paltiel, 1013 Weingarten, Scott R., 1109 Weiss , Richard L., 941, 986 , 1899 Weiss, Scott T ., 661 Weissberg, Dov, 321 Weitzenblum, Emmanuel, 1377 Wen, Ming-Shien, 937 Wendt, Christine H, 755 Werdan, Karl, 76, 970 West, John B., 1025 Wetter, David Wo, 524 Wewers, Mark D., 1600 Whelan, John, 1808 White, Carl W o, 855 White, John Eo, 589 White, Richard D., 931 Whiteneck, Gale G., 1292 Whitlock, Warren L., 647, 1299, 1610 Whittsett, J, 1215 Wichmann, Michael, 1622 Widmann, Joseph, 957 Wiggs, Barry R., 1365 Wijdicks, Edlco F., 602 Wiklund, Ingela, 1442 Wilcox, Pearce Go, 203 Wilde, Eric, 1887 Williams, David E., 49 Williams, Dennis M., 710

Williams, Randall, 718 Wilson, Jeffery 5., 1370 Wiman, Lars Go, 1298 W iner-Muram, Helen T ., 1516 Winkelmann, Bernhard R., 1383 Winn, Richard E., 412, 656 Winslow, Timothy M, 1286 Winters, Gayle, 585 Wirnsberger, Ruth, 1673 Wittman, Richard, 111 Wolf, Gregory T ., 777 Wolfkiel, Christopher J., 585 Wong, Poon G, 1624 Wood, John A., 798 Wood, Vivien So , 1908 Woodcock, Ashley A., 1127, 1133, 1624, 1630 Woods, Larry A., 1217 Wortham, Dale G, 389, 959 Worthen, G. 50,435,525, lOSS Wright, Robert 5., 489 Wright, Shawn E., 641 Wrisley, David A., 262 we. Delon, 937 Wu , Xaio. 175 Wundennk, Richard Go, 1516 Wurtemberger, Gebhard. 509 Xia, D, 1015 Yam, Loretta Y., 1722 Yamadori, Ichiro, 624 Yamagishi, Yoshifumi, 624 Yamaji, Yasufumi, 624 Yamakage, Mlchlakl, 860 Yamamoto, Makoto, 1399 Yamamoto, Masahiko, 1179 Yamane. Akira, 458 Yamazaki, Yutaka, 860 Yanagawa, Hiroaki, 1882 Yang. Pan-Chyr, 288, 646, 951 Yang. Shieh G , 1511 Yang, Sze P.• 1511 Yano, Heiichi, 307 Yanos, John. 1915 Yarzebski, Jorge, 1003 Yashima, Hiroshi, 1782 Yates, Helen, 741 Yavuzer,Sinasi, 1277 Yawn, David H ., 653

SUBJECT

Yazaki, Yoshio, 458 Yazawa, Takuya, 307 Ye, Tlng-tlng, 1713 Yebra, Miguel. 972 Yeh. Kun-Huei, 951 Yen San -jon, 937 Yellin, Alon, 1909 Yesildag, Osman, 1302 Yetter, Barbara, 701 Yew, Wing Wo, 1624 Yokouchi, Hideoki, 1884 Yokoyama, Mitsuhlro, 355 Yoshida , Kazuko, 317 Yoshimura, Masahiro, 631 Yotsumoto, Hideki, 458 Young. Eddy, 377 Young, James B., 897 Young, So K., 525 Young. Stuart W., 920 Yuan , Ang, 646 Yuksel, Mikail , 1302 Yun, Amy, 1879 Zabner,Joseph,1621 Zaccardelli, David, 1765 Zachgo, Wolfgang, 1285. 1622 Zahid, Mubashir A.• 1597 Zakowski, Phillip, 417 Zalcman, Gerard, 767 Zamora, Martin R., 296 Zan Bar, I., 138 Zapol, Warren M, 875 Zatti, Nicoletta, 449 Zavecz, James H.• 1545 Zhang. Yong Y.• 1693 Zidan, Favaz, 1013 Zlegler-Heitbrock, Hans w., 349 Zinns, Joseph S., 314 Zinny, Miguel, 1089 Zisch, Rainer J., 1254 ZuWallack, Richard L., 1046 Zubani, Roberto, 1625 Zucconi, Marco, 1301 Zucconi, Marco. 1759 Zurbrugg, Heinz, 1876 Zvetina, James Ro. 326 Zwick, Hartmut, 475

*Book reviewer

INDEX

Volume 105 (January-June 1994) Acetaminophen, hepatotoxicity of, in therapy of TB, 408 Acetylcholine, bronchial hyperresponsiveness to, in VSAP, 364 Acetylcysteine, enhances recovery from acute lung injury, 190 macrophage activation by, in COPD, 806 Acidos is. hyperventilation in sepsis and, 1632 Acquired im m unodeficiency syndrome: See also HIV infections diagnosis of PCP in, sputum induction vs BAL for , 650, 816 doxycycline pleurodesis for pneumothorax in, 823 pulmonary aspergillosis in, 37 Actlnobacdlus actlnomycetemcomtlans, pneumonia with possible embolization, 645 Acute disease, cardiac index and 02 extraction in, 1190

1934

prostatic, malignant pleural effusion from , 1577 Adenosine deaminase, increased activity in Q fever pneumonia, 648 raised pleural, does it mean TB? 1911 Adipose tissue, effect on variables of signal-averaged ECGs, 1357 Adrenal gland neoplasms. metastases from bronchogenic carcinoma, 1626 Adrenergic alpha receptor agonists, in successful treatment of labetalol overdose, 626 Adrenergic beta receptor agonlsts, dose-effect relationship of 2 in asthma, 1738 in combined therapy for COPD, 1089 in distinguishing between asthma and COPD, 1042 Aerosols: See also specific aerosol characteristics of DTPA and synthetic surfactant, 1765

pressurized metered-dose inhaler, 1621 saline. effect of sodium cromoglycate in airway narrowing induced by, 673 Age factors, in progression of aortic stenosis , 1902 mortality risk and, in acute MI, 1687 Aging. normal range of methacholine responsiveness. 661 AIDS: See Acquired immunodeficiency syndrome Air, secondary pulmonary lobule trapping, and emphysema-like changes, 1298 Airway resistance. changes in work of breathing during CPAP with increase in, 860 Airways, narrowing by saline aerosol, effect of sodium cromoglycate on. 673 peak pressure, why the fuss? 242 responsiveness and histamine tachyphylaxis

SubjectIndex.Vok.me 105(January-June, 1994)

in asthma, 1434 small, dysfunction in systemic sclerosis, 1922 Airway s obstruction, after esophagogastrectomy ,1921 among cotton textile workers , 1713 and recurrent respiratory infections, 1066 malignant, prolonged survival after radiation for , 767 persistence of, and hyperresponsiveness, 1024 physician estimation of FEV. in capo, 1709 regional, mucus transport in, 1420 Albumin, serum-effusion gradient in pleural effusions, 974 Albumins, blood : See Serum albulin Albuterol, ipratropium combined for capo, 1411 multidose dry powder inhalation device for , 1077 Alkaline phosphatase, distinguishing between pleural exudates and transudates, 1912 Almitrine bismes ylate, for hypoxemia in ARDS, 1579 low-dose for hypoxemia due to capo, 1383 Alpha l-antitrypsin, hereditary deficiency, replacement therapy for , 1406 phenotypes and asthma, 1905 Alpha adrenergic receptor agonists : See Adrenergic alpha receptor agonists Aluminum, eosinophilic lung reaction to, 1261 Alveolar lavage: See Bronchoalveolar lavage Alveolitis, allergic, role of C alblcans in chronic hypersensitivity pneumonitis, 317 lymphocytic, in crematorium worker, 617 Alveolitis, fibrosing : See Pulmonary fibrosis Amantadine, toxic effects in renal failure patients, 1630 Ambulatory care, comprehensive pulmonary rehabilitation for dyspnea, 1046 American Association 'of Respiratory Care, use of mechanical ventilation, erratum, 648 Amiodarone, development of ARDS after lung surgery related to, 1635, 1642 hemoptysis associated with, 305 pulmonary damage induced by, 965 Amphotericin, treatment of recurrent candidemia, 1597 Amrinone, effects on vascular resistance and capacity, 62 in successful treatment of labetalol overdose, 626 Amylase, concentrations in pleural effusion , 1625 Anaphylaxis, exercise-induced, ventricular fibrillation after, 620 Anemia, factitious hemoptysis and, 1629 hemolytic, cold-reacting autoantibody-mediated,288 pernicious, angina pectoris caused by, 653 Anesthesia, radial arterial pressure during, 69 Aneurysm, LV, rupture of, 1302 Angina pectoris, caused by pernicious anemia, 653 phantom, 1271 pron us, 1632 unstable, cardioprotective effect of, 57 variant, complicating ergot therapy, 1259 vasospastic, bronchial hyperresponsiveness to acetylcholine in, 364 Angiography, negative pulmonary, prognosis after, 1257 Angioneurotic edema, hereditary, and ARDS, 1898 Angioplasty, coronary, LV function after, 57 coronary, should all patients receive oxygen ? 727

coronary, survival of patients with LV dysfunction, 733 Angiotensin II, vasoconstrictor effects of, on pulmonary vascular bed, 1360 Anistreplase, treatment of Cuillain-Barre syndrome after MI, 1301 Anoxemia , almitrine for hypoxemia due to COPD,1383 almitrine for refractory hypoxemia in ARDS, 1579 hypoxemia during hyperbaric 02 therapy, 1270 hypoxemic RF following thrombolytic therapy for hemothorax, 1595 prognosis of severe hypoxemic patients, 335, 469 Anoxia, inhaled NO reverses hypoxic pulmonary vasoconstriction, 1842 Antibiotics, for low-risk hospitalized pneumonia patients, 1109 Antibodies, antibasement membrane disease and alveolar hemorrhage, 296 antineutrophilic cytoplasmic, in RA, 1590 anti phospholipid, prognostic factor in sarcoidosis? 1179 Anticoagulants, oral, 1903 oral therapy recommendations, 327 Antigens, Aspergillus, in urine, false-positive results, 975 bronchoconstriction induced by, in asthma, 483 CD14 , correlates, expression of, in pulmonary sarcoidosis , 349 in urine, pulmonary aspergillosis diagnosed by, 1304 squamous cell carcinoma, in diagnosis and prognosis of lung cancer, 773 Antiphospholipid antibodies: See Antibodies Antiphospholipid syndrome, lethal pulmonary embolism in patient with, 312 Antithrombotic agents: See Fibrinolytic agents Aorta, aortic root staphylococcic endarteritis with aortopulmonary fistula, 1631 aortobronchial fistula at site of aortic repair, 1249 ascending, distensibility of, in coronary disease, 1017 ascending, origin of right pulmonary artery from, 1280 Aortic coarctation, massive hemoptysis 17 years after repair of, 1249 TEE assessment of, 286 Aortic rupture, with intra-abdominal hemorrhage, TEE in, 1899 Aortic stenosis, calcific, coronary artery embolus with , 1289 progression of, 1902 valvular, LV remodeling in, 1273 Aortic valve, papillary fibroelastoma, 1885 Apnea : See also Sleep apnea syndromes what is hypopnea, anyway? 426 Arrhythmia, during IV pentamidine therapy, 389 during postural drainage and chest percussion, 1303 effects of ipratropium bromide on cardiac vagal tone, 1701 sinus arrest and dipyridamole infusion , 604 Arteries , systemic supply, scimitar sign with , 294 Arteriovenous malformations, pulmonary, TEE d iagnosis of, 1604 Arthritis, rheumatoid, alveolar hemorrhage with ANCA in, 1590 Asbestos, pleural fibrosis and impaired exercise

physiology induced by, 1312, 1370 pleural plaques, bronchial carcinoma and mesothelioma, 8, 144 spirometric impairments in long-term insulators, 175 Asbestosis, environmental, complicated by lung cancer, 1593 Aspen Lung Conference, 36th, acut e lung injury , Mar supp, 435-132S Aspergillosis, allergic bronchopulmonary, cav ernous destruction of upper lung lobe in, 1871 allergic bronchopulmonary, in CF, 32 pulmonary, diagnosed by antigen in urine, 1304 pulmonary, in AIDS patients, 37 Aspergillus, antigen in urine, false-positive resuits, 975 cutaneous infection, resection of chest wall and veins for, 1283 localized growth, in HIV-infected patients, 1285 Aspergillus [umigatus , sternal osteomyelitis due to, 1275 Aspiration, chronic, motor oil in lung, 326 foreign body, with mediastinal migration and vena cava penetration, 1923 iatrogenic, 976 occlusion of bronchus by expanding foreign body, 1600 pulmonary, in ventilated patients, 563 Asthma , actions of terbutaline potentiated by MgS0 4 ,701 aerosol corticosteroids in, 673 alphaj-antitrypsln phenotypes and , 1905 antigen-induced bronchoconstriction in, 483 breath sounds during histamine challenge, 122 cytokines and their cell sources in bronchial biopsy in, 687 distinguishing between capo and , 1042 dose-effect relationship of fenoterol and salbutamol in, 1738 effect of ipratropium bromide on intraocular pressure, 1439 effect of whole-body exposure to cold and wind in, 1728 effects of ipratropium bromide on cardiac vagal tone , 1701 eucapnic voluntary hyperventilation as bronchoprovocation technique in, 667 exercise testing in, 1127 histamine tachyphylaxis in, 1434 in female patients receiving steroids, bone mineral density in, 1640, 1722 index of awareness of symptoms of, 1430 inhaled salmeterol in, 1032 methacholine inhalation challenges, 1082 methotrexate in, perspectives on, 649 moderate, single or twice-daily use of beclomethasone in, 1732 partial 02 tension and lung mechanics during methacholine challenge in, 1905 persistent, after inhaling sodium hypochlorite and hydrochloric acid , 1895 plasma levels of leukotriene E 4 in, 1038 prevention, more on, 1906 recurrent, despite corticosteroid therapy, 1855 remission, persistence of airway obstruction in, 1024 requiring mechanical ventilation, 891 serum levels of IL-2R, IL-4, and FOfRII in,

CHEST/105/6/ JUNE 1994

1935

681 stable. single breath diffusing capacity for CO in. 1426 steroid-dependent. methotrexate in. 117 terbutaline powder in severe bronchial obstruction. 697 Atelectasis. left lung. in smoker. 1833 Atopic hypersensitivity. exercise testing in children with, 1127 Atrial fibrillation. nonrheumatic, left atrial appendage Bow patterns in. 748 paroxysmal, anti thrombotic therapy in, 971 recent-onset, treated with propafenone, 1013 Atrial myxoma : See Heart neoplasms Atrial natriuretic factor, increase in, in lungs . heart and circulatory system owing to ozone. 1551 Atr ioventricular node, pseudo-dissociation caused by ventricular extrasystoles, 1587 re-entry of common variety. 1869 Wenckebach periodicity causing ventricular preexcitation, 937 Atrium , interatrial right-to-left shunt after trauma, 1614 inte ra trial shunt after pneumonectomy. 931 left appendage Bow patterns in atrial fibrillation,748 Auscultation, percussion with. diagnosis of pulmonary abnormalities in HIV. 402 Autoantibodies, cold-reacting. hemolytic anemia mediated by, 288 Autoimmune diseases, polyglandular, and alveolar hemorrhage, 296 Bacteria, bronchial, in bronchitis. 976 culture. hygiene before expectoration of sputum for, 1923 Balloon dilatation. for bronchostenosis after lung transplant. 343 Basement membrane, alveolar hemorrhage due to antibody disease of, 296 Beclomethasone, single or twice-daily use in asthma, 1732 Beclomethasone dipropionate liposome, characteristics of 18 jet nebulizers with , 106 Beta adrenergic receptor agonists: See Adrenergic beta receptor agonists Biofeedback, breathing retraining assisted by. in CF, 23 Biopsy, bronchial. cytokines and their cell sources in, 687 lung. diagnosis of P car/nil and Aspergillus growth, 1285 lung. in diagnosis of BooP, 972 RV endomyocardial. in diagnosis of coronary atheroembolism,632 transbronchlal, massive clot following, 953 Biopsy. needle closed. in diagnosis of malignant pleural mesothelioma. 321 diagnosis of small-cell carcinoma, 1151 localization of peripheral lung nodules. 1559 risk of pneumothorax not increased by OLD in. 1705 transthoracic, bilateral pneumothorax after. 627 Bleomycin, pleurodesis for malignant pleural effusions , 1 Blister, right apical tense bulla causing SVC syndrome, 611 Blood, lymphocytic subpopulation profiles in. in tobacco and marijuana smokers, 847 multigated pool imaging. predictor of complications of lung resection, 1454

1938

peripheral, lymphocyte subsets in. in lung cancer, 1673 peripheral, lymphocyte subsets in. in sarcoidosis. 1474 Blood circulation. causes of reduced exercise tolerance. evaluation of. 1122 coronary, reestablishing during MI. 574 Blood coagulation. abnormalities in cancer patients, 1639 fatal hypercoagulability and TIA in lung cancer patients, 1639, 1683 system. role in ARDS, 268 Blood gases, arterial, plasma for analysis in leukemia, 954 pulse oximetry monitoring in stable patients. 1630 temperature in stability of, 1904 Blood pressure. radial artery, during anesthesia, 69 Blood transfusion. autologous, for surgical patients,856 Body, whole-body exposure to cold and wind in asthmatics, 1728 Body constitution. effect on variables of signalaveraged ECGs , 1357 Body temperature, pressure saturated, correction for ceramic flow sensor, 1481 Boerhaave's syndrome, complicated by bronchopleural fistula . 964 Bone, decreased mineral density in female asthmatics. 1640. 1722 glucocorticoid-induced loss. 1640 Bone marrow transplantation, alveolar hemorrhage and M homln/s infection after, 1891 lung transplants after, 327 pediatric lung transplant for GVHD after. 1584 Bookshelf , Jan pA-16, Feb p16. Mar p16. Apr p20, May p24, Jun p26 Brachytherapy, for malignant airway obstruction , prolonged survival after, 767 Breast neoplasms, pleural metastases from adenocarcinoma, 1557 Breathing: See Respiration Breathing exercises, biofeedback assisted , in CF,23 in preventing pulmonary complications after coronary surgery. 741 Bronchi. aortobronchial fistula at site of aortic repair, 1249 bacterial Bora in, in bronchitis, 976 biopsy. cytokines and their cell sources in, 687 biopsy. dissolution of massive clot after, 953 bronchopleuralfistula after pneumonectomy, 957 bronchopleural fistula in Boerhaave's syndrome.964 bronchorrhea from diffuse lymphangitic metastasis. 308 cast , left lung atelectasis, 1833 endobronchial lesions in HIV -infected individuals. 1314 endobronchial tuberculosis, 1910 endoscopic classification of TB. 318 hyperreactivity in system ic sclerosis, 1922 occlusion of main stem of, by expanding foreign body , 1600 treatment of bronchopleural fistula, 1879 Bronchial neoplasms: See also Carcinoma, bronchogenic bronchoalveolar cell, spread of. 1627 complete endobronchial occlusion by Kaposi's sarcoma, 1581

endobronchial lipoma, 1628 failure and survival in laser resection. 1668 hilar and mediastinal lymphadenopathy after resection of, 1251 pleural plaques and risk for. 8, 144 prolonged survival after radiation for airway obstruction from, 767 squamous cell carcinoma and respiratory papillomatosis. 1887 Bronchial provocation tests. breath sounds during histamine challenge, 122 comparison of industrial methacholine and Provochollne, 1095 eucapnic voluntary hyperventilation as, 667 histamine tachyphylaxis in asthma. 1434 hyperresponsiveness after cervical spinal cord injury, 1073 hyperresponsiveness to acetylcholine in VSAP. 364 methacholine inhalation challenges. 1082 methacholine partial 02 tension and lung mechanics during. 1905 methacholine. response in patient with diabetic neuropathy, 644 normal range of methacholine responsiveness,661 persistence of. in asthma remission. 1024 response in parents of infants with bronchiolitis,706 Bronchial spasm . exercise-induced, assessing, 1624 Bronchiolitis. acute. persistence of RSV genome and protein after, 1848 airway response to bronchodilators in parents of infants with. 706 Bronchiolitis obliterans organizing pneumonia. lung biopsy in, 972 with pneumatocele formation. 253 Bronchitis. chronic. bronchial bacterial Bora in. 976 chronic. ipratropium brom ide in ventilatorassisted patients with. 1511 plastic, left lung atlectasis in. 1833 Bronchoalveolar lavage, detection of lymphomatous involvement of lung by, 458 Buid profiles. 514 in farmer's lung disease, 1184 in sarcoidosis. lymphocyte subsets in. 1474 lymphocytic subpopulations in, in tobacco and marijuana smokers, 847 ontogeny of human polychlorinated biphenyl BP, 17 recovery of viruses from fluid, 1775 sepsis syndrome and death after. erratum, 648 study of idiopathic eosinophilic pneumonia. 1462 ultrastructural observation of P car/nil in. 1342 vs sputum induction in diagnosis of PCP, 650. 816 Bronchoconstriction, antigen-induced, in asthma.483 as cause of hypoventilation, 550 induced. index of awareness of asthma symptoms, 1430 stenosis after lung transplant, 343, 934 terbutaline in severe obstruction. 697 Bronchodllators, aerosol delivery, efficiency of, 214 airway response in parents of infants with bronchiolitis, 706 effect of terbutaline in bronchial obstruction, 697

Subject Index. Volume 105 (January.JWl8. 1994)

Bronchopulmonary dysplasia, human polychlorinated biphenyl BP in tracheal aspirates in, 17 Bronchopulmonary sequestration, extralobar , 1919 scimitar syndrome or? 294 Bronchoscopy, fiberoptic and intracranial pressure, 1909 diagnosis of cavitary coccidioidomycosis, 412 in diagnosis of bronchogenic carcinoma, 1663 in endobronchial TB, 1910 in evaluation of metastatic carcinoma of lung, 454 prospective HRCT correlation in hemoptysis, 982, 1155 scopist variability in diagnosis of lung cancer , 1658 Cachexia, cardiac, surgical treatment, 1347 Calcification, in aortic stenosis, coronary artery embolus with, 1289 mitral valve, in LV dysfunction, 383 Candida albuxms, role in chronic hypersensitivity pneumonitis, 317 Candida parapsilosis, probable prosthetic valve endocarditis, 1597 Carbon dioxide: See also Hypercapnia efficiency of removal of, in ARF, 1198 eucapnic voluntary hyperventilation, 667 expired capnogram and respiratory system resistance in critically ill, 219 Carbon monoxide, single breath diffusing capacity for, in asthma, 1426 Carcinoma, bronchial, pleural plaques and risk for, 8, 144 bronchoalveolar cell, endobronchial spread of, 1627 bronchogenic, adrenal gland metastases and staging of, 1626 bronchogenic , FOB in diagnosis of, 1663 hepatocellular, right atrial metastasis of, 945 laryngeal , cardiac metastasis from, 1304 lung, in patient with plombage thoracoplast y, 1622 lung, pulmonary complications after thoracotomy for, 760 metastatic lung, bronchorrhea from, 308 metastatic lung, FOB in evaluation of. 454 mucoepidermoid, lymphadenopathy after resection of, 1251 small-cell, endobronchial aspiration in diagnosis of, 1151 small-cell, lung, peripheral blood lymphocyte subsets in, 1673 small-cell, of lung and myasthenia gravis, 624 squamous cell, antigen in diagnosis and prognosis of lung cancer, 773 squamous cell, bronchogenic, and respiratory papillomatosis, 1887 squamous cell, of lung, radiation therapy in, 132 Cardiac care units, pediatric, surface echocardiography in, 10 Cardiac index, and 02 extraction in the acutely ill, 1190 Cardiac tamponade, complicating malignant thymoma, 941 secondary to giant lymph node hyperplasia , 637 Cardiomyopathy, acute reversible, 298 Cardiopulmonary bypass, effect of surfactants on lung function after , 421

Cardiopulmonary disease, clinical problems in, syncope, diagnosis and management, 1246 Cardiopulmonary system, discordance between physiology and physical therapy , 322 Cardiorespiratory system, effects of inverse ratio ventilation on, 646 Cardiovascular agents, mortality and use of, in acute MI, 1687 Cardiovascular system, actions of terbutaline potentiated by MgS0 4, 701 increase in ANF in circulatory system owing to ozone, 1551 Carmustine, diffuse interstitial pneumonitis induced by, 1602 Cartilage, transient swelling of costochondral and sternal region in infants, 29 Castleman's disease: See Giant lymph node hyperplasia Catheter, Ballard, BALby, vssputum induction in diagnosis of PCP, 650, 816 brush, accuracy of portable chest radiography in diagnosis of pneumonia using, 885

Fogarty , and Surgicel for bronchopleural fistula, 1879 interventional rad iology concerns, 643 pulmonar y artery , use in critical care, 643 transtracheal, vs nasal prongs for 02 delivery , 1061 Catheterization, cardiac, should all patients receive oxygen? 727 central venous, unusual complication of, 905 femoral vein pulmonar y artery, in the ICU, 874 pulmonary artery, in Ml, 1003 CD4+, T-Iymphocyte depletion in TB patients, normalization of, 1335 CDI4: See Antigens Cellulose, Surgicel and Fogarty catheter for bronchopleural fistula, 1879 Central venous catheterization: See Catheterization Ceramic flowsensor, BTPScorrection for, 1481 Cerebrovascular disorders, swallowing and cough reflexes after stroke, 1623 Chemotherapy, intrathoracic, following panpleuropneumonectomy, 1884 lung transplant for pulmonar y fibrosis induced by, 310 Chest, acclaimed executive editor , Sylvia J. Peterson, 1633 Chest, Castleman's disease of, 1608 is CT performed too often? 647 percussion, arrhythmia during, 1303 physiotherapy vs intrapulmonary percussive ventilation , 1789 surgery, preoperative respiratory muscle training, 1782 thoracic neurofibromatosis with breathlessness, 589 wall echinococcosis, 1277 wall, resection for invasive Aspergillus infection, 1283 Chest pain, prognosis and symptoms I year after discharge from ER, 1442 Chest roentgenography, portable , accuracy of, in critical care, 885 Chest tubes, failure to wean from ventilator and , 1292 Child, effect of ipratropium bromide on intraocular pressures in, 1439 high-frequency ventilation for respiratory failure in, 652 lung transplantation for GVHD after marrow

transplant in, 1584 normal and atopic , exercise testing in, 1127 prolonged use of endotracheal tube changer in, 961 Chlamydia pneumoniae, infection in former injection-drug users, 812 infections, 1914 Chlorambucil, pneumonitis associated with, 634 Cholesterol, prevention and regression of coronary atherosclerosis. 718 Chondroma, multiple pulmonary , cause of neonatal respiratory distress, 301 Chondrosarcoma, tracheal, with dyspnea, 1555 Chordae tendinae, ruptured tricuspid valve, TEE diagnosis of, 1286 Chylothorax, in Gorham 's syndrome, 208 Clinical competence, medical personnel and inhaling devices, III Clubbed fingers, in idiopathic pulmonary fibrosis,339 Cocaine, crack, Leffler 's syndrome secondary to, 1599 pregnancy complicated by, and sarcoid cardiomyopathy, 303 Coccidioidomycosis, cavitary, with fungus ball formation, 412 pulmonary , with pleural effusion, 918 Cold, whole-body exposure in asthmatics to wind and, 1728 College, aeep medical personnel services, Jan pA-25, Feb p26, Mar p22, Apr p32, May p28, [un p39 message from ACCP Government Liaison Committee, 1572 Colonic neoplasms, bronchorrhea from lyrnphangitic metastasis of, 308 Contrast media, pulmonary edema associated with,641 Cor triatriatum, biplane TEE diagnosis of, 332, 601 sinistrum, double outlet RV with, 290 Coronary arteriosclerosis. prevention and regression of atherosclerosis, 718 Coronary artery, atheroembolism , diagnosis of, 632 fistula diagnosed by TEE, 959 normal, ventricular fibrillation after exerciseinduced anaphylaxis with, 620 pathoanatomy in acute inferior MI, 360 reestablishing blood flow in, during Ml, 574 spontaneous embolus, 1289 surgery, exercises in preventing pulmonary complications after, 741 Coronary artery bypass grafting, RV function dur ing weaning from respirator after, 1352 Coronary disease, distensibility of ascending aorta in, 1017 role in progression of aortic stenosis, 1902 survival after PTCA in patients with LV dysfunction, 733 Corticosteroids, aerosol. in asthma , 673 bone mineral densit y in female asthmatics receiving. 1640, 1722 inhaled, effect on histamine tachyphylaxis in asthma, 1434 inhaled , in eosinophilic pneumonia, 1913 methotrexate in asthma dependent on, 117 preoperative, 1908 recurrent asthma despite therapy with, 1855 rescue treatment in late ARDS, 1516 Cost-benefit analysis, new therapy. fiduciary responsibility, 329 Cotton, gossypibomas mimicking echinococcal cyst, 284

CHEST/105/6/ JUNE 1994

1937

textile workers, pulmonary function among, 1713 Cough, dyspnea, lLD and, 265 exercise in preventing pulmonary complications after coronary surgery, 741 fever and cavitating pulmonary lesions with, 591 in pulmonary coccidioidomycosis with pleural effusion, 918 reflexes after stroke, swallowing and, 1623 refractory, nebulized lidocaine in, 1592 unproductive, in airways obstruction, mucus transport in, 1420 ventricular tachycardia induced by , 1583 Counseling, different treatments and effectiveness of nicotine patch, 524 Critical care, board examination resources, erratum,648 Medicare, Clinton health plan, and, 1305 role of coagulation system in ARDS, 268 selective decontamination of digestive tract, 978 , 1221 use of pulmonary artery catheter in, 643 Critical care, clinical investigations in accuracy of portable chest radiography, 885 adverse environmental conditions in lCUs, 1211 asthma requiring mechanical ventilation, 891 cardiac index and 02 extraction in acute illness, 1190 causes of hypoventilation with high inspiratory pressures, 550 common ventilatory modes, 1798 corticosteroid rescue treatment in late ARDS, 1516 effect of PPV on impedance plethysmography, 1813 efficiency of bronchodilator aerosol delivery, 214 endotracheal tube resistance, 1794 expired capnogram and respiratory system resistance, 219 femoral vein pulmonary artery catheterization, 874 hypermetabolism and efficiency of C02 removal in ARF , 1198 ipratropium in ventilator-assisted bronchitis patients, 1511 lateral radiographs in the lCU, 560 management of acute respiratory failure, 229 mucociliary transport in lCU patients, 237 name that tone, 1217 predictors of TPN-induced lipogenesis, 553 prostacyclin in septic shock, 1504 pulmonary aspiration in ventilated patients,

563

rapid shallow breathing and extubation, 540 rapid visualization of massive pulmonary emboli, 888 resting energy expenditure in ventilated patients,544 risk for early onset pneumonia in trauma patients, 224 severe community-acquired pneumonia, 1487 stomach is not source for infection in the ICU, 878 unplanned extubations, 1804, 1808 urine hydrogen peroxide in ARDS , 232 weaning from mechanical ventilation, 534 , 1204 Critical illness, expired capnogram and respiratory resistance in, 219 impact of unsuspected pulmonary thromboembolism in, 986

1938

in pregnancy, 1915 phenytoin toxicity and hypoalbulinemia in,

602

what is "guarded condition" anyway? 649 Cromolyn sodium, effect on airway narrowing induced by saline aerosol, 673 Cross infection, nosocomial, caused by methicillin-resistant S aurew, 826 of P cepacia, potential of, in cardiopulmonary transplant centers, 1630 respiratory tract isolates of H a/vet, 1098 selective digestive tract decontamination, 978, 1101, 1221 Cyclophosphamide, false-positive results for Aspergillus antigen, 975 Cystic fibrosis, allergic bronchopulmonary aspergillosis in, 32 biofeedback assisted breathing retraining in, 23 erythrocytic glutathione in, 1470 home exercise training program for, 334, 463 intrapulmonary percussion vs chest physiotherapy in, 1789 lung transplant for, P cepacia empyema necessitatis after, 1888 quality of life before and after lung transplant for , 911 Cysts, large air-filled, in BOOP, 253 pleural multicystic mesothelial proliferation, 295 Cytokeratin, typing of human lung tumors, 138 Cytokines, and their cell sources in bronchial biopsy , 687 proinBammatory, role in congestive heart failure, 897 Cytology, analysis and typing of human lung tumors, 138 Cytomegaloviruses, infection after lung transplantation, 929 recovery of other viruses from BAL Buid, 1775 Cytometry: See Flow cytometry Cytoplasm, antineutrophilic cytoplasmic antibodies in RA, 1590

Decontamination, selective, of digestive tract, 978, 1101, 1221 Deglutition, swallowing and cough reflexes after stroke, 1623 Dextromethorphan, test for evaluation of predisposition to lung cancer, 449 Diabetic neuropathies, bronchial responsiveness to methacholine in, 644 Digestive tract, selective decontamination of, 978 , 1101, 1221 Dipyridamole, infusion and sinus arrest, 604 Disease, systemic, single lung transplant in patients with, 837 Disseminated intravascular coagulation, complicating malignant thymoma, 941 fatal, in lung cancer patients, 1639, 1683 Dopamine, for hyperdynamic septic shock, 7 Dose-response relationship, of fenoterol and salbutamol in asthma, 1738 Doxycycline, for pleurodesis, efficacy of, 1743 pleurodesis for pneumothorax in AIDS, 823 Drainage, postural, arrhythmia during, 1303 Drug abuse: See Substance abuse Drug hypersensitivity, acetaminophen, hepatotoxicity of, 408 amantadine, toxic effects in renal failure, 1630

amiodarone and development of ARDS, 1635, 1642 amiodarone-associated hemoptysis, 305 amiodarone-induced pulmonary damage, 965 carmustine, interstitial pneumonitis induced by, 1602 chemotherapy-induced pulmonary fibrosis, 310 chlorambucil-associated pneumonitis, 634 corticosteroids, decreased bone mineral density and, 1640, 1722 dipyridamole, sinus arrest associated with, 604 ergot, variant angina after use of, 1259 erythromycin-induced torsades de pointes, 368

glucocorticoid-induced bone loss, 1640 glycerol trinitrate, paradoxic hypertension induced by , 1621 heparin, can it cause ARDS? 1266 interferon alfa, pneumonitis from, 939 labetalol overdose successfully treated, 626 neuroleptic-induced respiratory dyskinesia, 1826 pentamidine, arrhythmias during IV use, 389 petroleum jelly, lipid pneumonia from nasal use, 968 phenytoin toxicity and hypoalbuminemia, 602 radiocontrast material, pulmonary edema from, 641 verapamil overdose, pulmonary edema from, 606

Drug resistance, multidrug-resistant TB, 45 Dyskinesia, respiratory, underrecognized, 1826 tardive, respiratory dysrhythmias in, 203 Dyspnea, cardiopulmonary exercise testing in evaluation of, 168 comprehensive outpatient rehabilitation for, 1046 cough, ILD and, 265 effect of low and high Bow 02 on sensation of, 1061 in tracheal chondrosarcoma, 1555 index of awareness of asthma symptoms, 1430 platypnea after pneumonectomy, 931 platypnea related to constrictive pericarditis,

636

progressive, with pleurisy and hemoptysis, 1557 years after poliomyelitis, 777

Ear, middle, sarcoidosis of, 1582 Echinococcosis, chest wall , 1277 of lung, gossypibomas mimicking, 284 Echocardiography, biplane TEE diagnosis of cor lriatriatum, 332, 601 biplane TEE, in dynamic RV outBow obstruction, 610 coronary artery fistula diagnosed by TEE, 959 diagnosis of LV aneurysm rupture, 1302 diagnosis of aortic valve papillary fibroelastoma,l885 Doppler analysis of pulmonary venous Bow, 315 in aortic rupture with intra-abdominal hemorrhage, 1899 Subject Index,VoUne 105 (January.JInI, 1994)

new pulsed Doppler techniques, 1902 of right atrial metastas is, 945 surface, in pediatric CICU, 10 TEE assessment of aortic coarctation, 286 TEE diagnosis of pulmonary AV malformation, 1604 TEE diagnosis of ruptured tricuspid valve chordae tendinae, 1286 TEE diagnosis of traumatic mediastinal hematoma, 331, 373 TEE in diagnosis of infective endocarditis, 333, 377 Edema: See also Pulmonary edema peripheral, pulmonary hemodynamics in capo before and after episode of, 1377 transient swelling of costochondral and sternal region in infants, 29 Education, medical, continuing, documentation of, 1 Electric impedance, for diagnosis of pulmonary mass, 1679 Electrocardiography, coronary pathoanatomy in acute inferior MI, 360 in acute Ml, 3 signal-averaged, effect of body characteristics on, 1357 unique finding after esophagectomy, 1613 Embolism : See also Pulmonary embolism diagnosis of coronary artery atheroembolism, 632 possible, in A actlnomycetemcomltans pneumonia,645 spontaneous coronary artery, 1289 Emergency department, prognosis and symptoms 1 year after discharge from, 1442 Emphysema, changes like, may be pulmonary lobule air trapping, 1298 pulmonary vascular resistance in, 798 respiratory load compensation during hypercapnic ventilatory response in 1399 Emphysema, subcutaneous: See Subcutaneous emphysema Empyema, P cepocia, necessitatis, after lung transplant, 1888 parapneumonic, early aggressive surgical management of, 832 Endarteritis, aortic root staphylococcic, 1631 Endocarditis, infective, TEE in diagnosis of, 333,377 probable Cparapsilosis prosthetic valve, 1597 Endoscopy, classification of tracheobronchial TB,318 video-, removal of mediastinal cyst, 1254 Energy metabolism, resting expenditure in ventilated patients, 544 Environment, adverse conditions in lCUs, 1211 Environmental exposure, asbestosis compli cated by lung cancer, 1593 Eosinophilia, pleural fluid, in pulmonary eoccidioidomycosis,918 Eosinophilia, pulmonary: See Pulmonaryeosinophilia Eosinophilic granuloma, gamma/delta T cells in, 967 pulmonary histiocytosis X, 265 Eosinophilic pnenmonia: See Pulmonary eosinophilia Eosinophils, pulmonary involvement in hypereosinophilic syndrome, 656 Ergonovine, positive test in ventricular fibrillation after exercise-induced anaphylaxis, 620 Ergot , therapy of migraine, variant angina complicating, 1259

Erythrocytes, glutathione in, in CF, 1470 NK cell granular proliferative disorders and pulmonary nodules, 1893 Erythromycin, does not directly affect neutrophil function, 520 torsades de pointes induced by, 368 Erythropoietin, recombinant, injection and autologous transfusion for surgical patients, 856 Esophageal perforation, surg ical repair of, in cirrhotic patients, 1896 Esophageal varices, cirrhotic patients, repair of esophageal perforation in, 1896 Esophagectomy, tracheal occlusion after, 1921 Esophagus, rupture, Boerhaave 'ssyndrome, 964 Ethics in cardiopulmonary med icine, MRI marketing and investment, 920 Exercise, assessing bronchospasm induced by, 1624 effects of PEP during, in capo, 782 impaired physiology induced by asbestos, 1312, 1370 incremental and maximal, heart rate and 02 uptake during, 1365 limitation in interstitial lung disease, 183 mild, normal pulmonary function and blood flow values during, SOl reanalysis of 12-minute walk in capo, 163 reduced tolerance, CP exercise testing in evaluating, 1122 submaximal, 02 uptake for, in HF , 1693 tolerance, effect of low and high flow 02 delivery on, 1061 ventricular fibrillation after anaphylaxis induced by, 620 Exercise and the heart , trainability of arms vs legs after MI, 262 Exercise test, cardiopulmonary, in evaluation of dyspnea, 168 in evaluating high-risk patients for resection, 1617 in evaluating reduced exercise tolerance, 1122 response in normal and atopic children, 1127 role of, in dyspnea years after poliomyelitis, 777 silent ischemia detected by stress testing, 1009 Exercise therapy, home program for CF patients, 334, 463 inspiratory muscle, for MD patients, 475 preoperative respiratory muscle, 1782 trainability of arms vs legs after Ml, 262 Extrasystole, interpolated ventricular, pseudoA-V dissociation caused by, 1587 Exudates and transudates, pleural , alkaline phosphatase in distinguishing between, 1912 pleural effusions, separation of, 974 postural changes in pleural fluid constituents, 1458

Factitious disorders, hemoptysis, 943 hemoptysis and anemia, 1629 Faculty, start ing an academic career, 1858 False-positive reactions , for Aspergillus antigen, cyclophosphamide induces, 975 Farmer's lung disease, mast cell and histamine involvement in, 1184 Fats, predictors of TPN-induced lipogenesis,

553 FCfRII: See Receptors Femoral vein, catheterization in the ICU, 874 Fenoterol, dose-effect relationship of, in asthma, 1738 Fever, cough and cavitating pulmonary lesions with,591 in pulmonary coccidioidomycosis with pleural effusion, 918 Fiberglass , treating plombage complications, 1622 Fibrinolytic agents , for hemothorax, hypox em ic RF following, 1595 in paroxysmal atr ial fibrillation, 971 recommendations on use of, errata, 647 Fibroelastoma, aortic valve papillary, 1885 Fibrosis, perivascular, of muscular pulmonary arteries in COPD, 973 pleural, induced by asbestos, 1312, 1370 Financial management, efficacy/cost ratio of new therapy, 329 Fistula, aortobronchial, at site of aortic repair, 1249 aortopulmonary, staphylococcic endarteritis with, 1631 bronchopleural, after pneumonectomy, 957 bronchopleural, complicating Boerhaave's syndrome, 964 bronchopleural, treatment with Fogarty catheter and Surgicel, 1879 coronary artery, diagnosed by TEE, 959 Fixation, external, of subglottic tracheal stents, 1653 Flow cytometry, expression of surface markers on alveolar macrophages detected by, 1324 Fluconazole, treatment of recurrent candidemia, 1597 Forced expiratory flow, in airways obstruction, mucus transport in, 1420 Forced expiratory volume , among cotton textile workers, 1713 physician estimation of FEV I in capo, 1709 Foreign bodies, aspiration with mediastinal migration, 1923 endotracheal tube cuff fragments, during tracheostomy, 644 gossypibomas mimicking echinococcal cyst, 284 rapidly expanding, occlusion to bronchus by, 1600 Funnel chest, pulmonary function before surgery for pectus excavatum, 1646 Gamma/delta T cells, circulating, in eosinophilic granuloma, 967 Gangrene, pulmonary, complication of pneumonia,567 Gastrectomy, tracheal occlusion after esoph-

agogastrectomy, 1921 Gene rearrangement, in detection of lymphomatous involvement of lung, 458 Genome , RSV, persistence of, after bronchioli tis, 1848 Giant lymph node hyperplasia, cardiac tamponade secondary to, 637 Castleman's disease of chest, 1608 Glottis, external fixation of subglottic tracheal stents, 1653 Glucocorticoids, bone loss induced by, 1640 Glutathione, erythrocytic, in CF , 1470 Gorham 's syndrome: See Osteolysis CHEST/105/6/ JUNE 1994

1939

Government, message from ACCP Government Liaison Committee, 1572 Graft vs host disease , following marrow transplant, pediatric lung transplantation for , 1584 Granuloma, eosinophilic: See Eosinophilic granuloma Granuloma, plasma cell pulmonary, corticosteroid therapy, 1574 Cuillaln-Barre syndrome, after acute MI, 1301

Hafnia aloei, respiratory tract isolates in hos-

pital, 1098 Head, position as factor in endotracheal tube resistance, 1794 Health personnel, knowledge of and ability to use inhaling devices, 1I 1 Health services accessibility, rationing care in the US, 984 Heart, catheterization, should all patients receive oxygen? 727 effects of ipratropium bromide on vagal tone of, 1701 increase in ANF in, owing to ozone , 1551 thrombus. life-threatening pulmonary embolism with, 1291 Heart arrest, sinus, and dipyridamole infusion. 604 Heart block , infra-His Mobitz type A-V, with hypokalemia, 1616 pseudo-A-V dissociation caused by ventricular extrasystoles, 1587 Heart failure, chronic, respiratory muscle strength in, 355 chronic, submaximal exercise and recovery in, 1693 congestive. amrinone in, 62 congestive, basic mechanisms in, 897 pulmonary hemodynamics in COPD, 1377 Heart neoplasms, familial myxoma, 65 interleukin-6 secreting myxoma in LV. 962 left atrial myxoma presenting as acute RF , 1282 metastasis from laryngeal carcinoma. 1304 pulmonary venous flow in left atrial myxoma, 315 right atrial metastasis of hepatocellular carcinoma,945 'torsades de pointes' with left ventricular myxoma. 1876 Heart rate, prediction of, during incremental and maximal exercise, 1365 variability during sleep in snorers, 1300 Heart surgery, early treatment of sepsis after, 76 fatal phrenic nerve injury following hypothermia during. 1268 for cachexia. 1347 sternal osteomyelitis due to A fum/gatllS after , 1275 surface echocardiography in pediatric ICU, 10 Heart transplantation, centers, potential of nosocomial P cepacia in, 1630 measurement of RV volume in explanted hearts, 585 Heart valve prosthesis, proble C parapsilosts endocarditis. 1597 Hematoma. traumatic mediastinal, diagnosis. 331 ,373 Hematopoiesis, extramedullary, in lung, agnogenic m yeloid metaplasia with. 1866 Hemodynamics, characteristicsof common ventilatory modes, 1798

1940

in chronic heart failure, 355 noninvasive, during lavage in alveolar proteinosis, 1605 pulmonary, in COPD, 1377 Hemoptysis, amiodarone-associated, 305 dyspnea and pleurisy with, 1557 factitious, 943 factitious anemia and. 1629 massive, 17 years after repair of aortic coarctation, 1249 prospective HRCf/bronchoscopic correlation, 982. 1155 Hemorrhage, alveolar, with ANCA in RA, 1590 diffuse alveolar, in bone marrow transplant recipient, 1891 diffuse alveolar, in polyglandular autoimmune syndrome, 296 intra-abdominal. and aortic rupture, TEE in, 1899 Hemothorax, hypoxemic RF following thrombolytic therapy for, 1595 Heparin, can it cause ARDS? 1266 Hepatitis. hepatotoxicity of acetaminophen. 408 Hepatitis C, pneumonitis associated with interferon alfa therapy for, 939 Hepatoma, right atrial metastasis of, 945 Hereditary diseases. alphaj-antitrypsin deficiency, replacement therapy for , 1406 Histamine, challenge, breath sounds during, 122 involvement in farmer's lung disease , 1184 tachyphylaxis in asthma, 1434 Histiocytosis X, pulmonary, 265 HIV infection: See also Acquired immunodeficiency syndrome antigen expression on alveolar macrophages in. 1324 arrhythmias during IV pentamidine therapy in, 389 diagnosis of P car/nil and Aspergillus growth in. 1285 endobronchial lesions in individuals with . 1314 normalization of CD4+ T-Iymphocyte depletion in patients without, 1355 pleural TB and, 1338 rapid clinical diagnosis of pulmonary abnormalities in, 402 regional deposition and ventilation during inhalation of pentamidine in, 396 S aureus pericarditis in patients with, 615 sarcoidosis and, 1299 sputum induction vs BAL to diagnose PCP in, 650,816 syphilitic pneumonitis and, 629 Hodgkin's disease, BAL fluid profiles in, 514 nodular sclerosing, stage IV, 591 Home care. exercise training program for CF patients, 334. 463 high-technology, 4 technology assessment and support of lifesustaining devices in. 1448 Hospital infections: See Cross infection Hydatid cyst : See Echinococcosis Hydrochloric acid, inhalation of sodium hypochlorite and , persistent asthma after, 1895 Hydrogen peroxide, urine, during ARDS, 232 Hygiene, oral, before expectoration for bacterial culture, 1923 Hyperbaric oxygenation, hypoxemia during, 1270 Hypercapnia, in COPD. NPV im proves respiratory function in. 87

respiratory drive in nonhypercapnic obese patients with sleep apnea. 1917 short-term NIPPV in severe OSA and, 434 ventilatory response in emphysema, 1399 Hyperplasia, giant lymph node: See Giant lymph node hyperplasia Hypertension, multiple peripheral pulmonary artery branch stenosis in, 1294 paradoxic, glyceroltrinitrate-induced, 1621 pulmonary, chronic thromboembolic, 1619 pulmonary, primary, symposium, Feb supp, 15-41S Hyperventilation, eucapnic voluntary. bronchoprovocation technique, 667 in sepsis and acidosis , 1632 Hypokalemia, with second degree A-V block, 1616 Hypophosphatemia, in resp iratory failure due to COPD, 1392 Hypopituitarism. pan-, caused by metastatic lung cancer. 951 Hypopnea, what is it, anyway? 426 Hypopotassemia: See Hypokalemia Hypothermia. induced, fatal phrenic nerve injury following, 1268 Hypothyroidism, OSAS and. 1296 Hypoventilation, central alveolar. in recurrent acoustic neuroma. 949 with high inspiratory pressures, causes of, 550 Hypoxemia: See Anoxemia Hypoxia: See Anoxia

Iatrogenic disease, aspiration, 976 spontaneous subcutaneous emphysema or? 321 pneumothoraces. significance of , 980, 1147 ICI 204,219 : See Leukotriene antagonists IgG, recurrent respiratory infections and deficiency of, 1066 Immigration, TB among immigrants, 1911 Immunity, immune function in squamous cell lung carcinoma, 132 Immunocompromised host. invasive cutaneous Aspergillus infection in. 1283 Immunodeficiency syndrome. acquired: See Acquired immunodeficiency syndrome Immunoglobulins. early treatment of sepsis after cardiac surgery with, 76 Immunophenotyping, detection of lymphomatous involvement of lung by, 458 Immunosuppressive agents, radiographic course of Wegener's granulomatosis under therapy with , 509 Infant. high-frequency ventilation for respiratory failure in, 652 transient swelling of costochondral and sternal region in, 29 Infection, early treatment of sepsis after cardiac surgery, 76 evaluation of definitions of sepsis, 970 hyperventilation in sepsis and anemia, 1632 "infective" MI, 1618 urine H202 in ARDS with sepsis, 232 Inflammation, systemic inflammatory response syndrome and sepsis, 970 systemic response syndrome in acute reversible cardiomyopathy. 298 Inguinal canal, lymphangioma extending from mediastinum to, 1279 Inhalation therapy: See Respiratory therapy Inhalers: See Nebulizers Inpatients, low-risk. with pneumonia, identfflSubject Index. Volume 105 (January.JLnl. 1994)

cation of, 1109 misuse of MDIs in, 715 Insurance, health, Medicare. critical care and Clinton health plan, 1305 Intensive care units. femoral vein pulmonary artery catheterization in. 874 lateral radiographs in. 560 mucociliary transport in patients in, 237 proliferation of alarms in. 1217 respiratory and medical, adverse environmental conditions in, 1211 stomach not source of infection in. 878 Interferon-alpha, therapy for hepatitic C. pneumonitis after. 939 Interferons, recombinant IL-l beta and gamma. effect on septic lung injury, 1241 Interleukin-lB, recombinant, effect on septic lung injury, 1241 Interleukin-S, myxoma secreting, in LV, 962 Interleukins, serum levels of IL-2R and IL-4 in asthma, 681 Internship and residency, revisiting the Libb y Zion case , 977 Intracranial pressure, FOB and. 1909 Intraocular pressure. effect of nebulized ipratropium bromide on. 1439 Intubation, pulmonary aspiration in ventilated patients. 563 rapid shallow breathing and extubation out come, 540 unplanned extubations, 1496, 1804, 1808 Intubation, tracheal laceration of cuff during tracheostomy. 644 prolonged use in pediatric patient. 961 tube as cause of hypoventilation with high inspiratory pressures, 550 tube resistance, factors determining. 1794 Ipratropium, aerosol. effects on cardiac vagal tone . 1701 albuterol combined for COPD. 1411 in ventilator-assisted bronchitis patients,1511 inhaled, vs oral theophylline in combined therapy in COPD, 1089 nebulized. effect on intraocular pressure, 1439

Jurisprudence, revisiting the Libby Zion case, 977

Kidney. end-stage disease. LV dysfunction in, 383 failure, toxic effects of amantadine in, 1630 necrotic. system ic inOammatory response syndrome due to, 298 Killer cells, natural, granular lymphocyte proliferative disorders, pulmonary nodules in, 1893

Labetalcl , overdose successfully treated, 626 Laboratory and animal investigations. estimation of triggering work of breathing, 1836 extending lung preservation. 255 hypoxic pulmonary vasoconstriction, 1842 increase in ANF owing to ozone, 1551 measurement of RV volume in explanted hearts, 585 pleurodesis with polidocanol, 908

preservation of pulmonary function. 1545 septic acute lung injury. 1241 persistence of RSV genome and protein. 1848 Laryngeal neoplasms, cardiac metastasis from , 1304 Lasers, endobronchial resection with, failure and survival in, 1668 Lavage: See also Bronchoalveolar lavage lung, in primary alveolar proteinosis, 1605 Legionnaires' disease , lymphocytic interstitial pneumonitis after. 325 review , 1817 Legislation, message from ACCP Government Liaison Committee. 1572 Leukemia, plasma for ABG anal ysis in, 954 Leukotriene antagonists. ICI 204. 219 blocks antigen-induced bronchoconstriction, 483 Leukotrienes, E•• plasma levels in asthma. 1038 Lidocaine. nebulized. for refractory cough, 1592 Life expectancy, in severe COPD, 335 Life support care, technology assessment and support of devices in home care, 1448 Lipoma, endobronchial, 1628 Liposomes, beclomethasone dipropionate, characteristics of 18 jet nebulizers with , 106 Liver. cirrhosis with varices. repair of esopha geal perforation in patients with , 1896 hepatopulmonary syndrome, 1528 Leffler 's syndrome: See Pulmonary eosinophilia Lorazepam, continuous infusion oral, 1915 Lucite, sphere plombage thoracoplasty, lung carcinoma with , 1622 Lung, acute injury from mercury inhalation, 613 acute injury, 36th Aspen Lung Conference, Mar supp, 435-1325 aspiration in ventilated patients, 563 biopsy , diagnosis of P car/ntl and Aspergillus growth by , 1285 biopsy in diagnosis of BOOP, 972 chronic aspirated motor oil in, 326 enhanced recovery from acute injury to, 190 entrapment and failure to wean from ventilator, 1292 hemodynamics in COPD, 1377 increase in ANF in, owing to ozone , 1551 lavage in primary alveolar proteinosls, 1605 left upper lobe and reticular-nodular in61trate, 1864 mechanics during methacholine challenge, 1905 ontogeny of human polychlorinated biphenyl BP, 17 secondary lobule air trapping, emphysemalike changes may be, 1298 septic injury in mice, 1241 surgery, autologous blood transfusion for , 856 upper lobe, cavernous destruction of, 1871 Lung disease, interstitial: See Pulmonary Bbrosis Lung diseases: See Pulmonary diseases Lung transplantation, after prior bone marrow transplants, 327 bilateral. for CF, quality of life before and after, 911 centers, potential of nosocomial P cepacia in, 1630 for chemotherapy-induced pulmonary fibrosis, 310 in CF, P cepacia empyema necessitatis after, 1888

inhaled pentamidine in rec ipients of, 417 management of bronchostenosis after, 343 pediatric, forGVHD following marrow transplantation, 1584 pneumatosis intestinalis and CMV infection after, 929 preoperative corticosteroids a contraindication to? 1908 preservation after prostaglanding EI infusion, 255 single, bronchial stenosis after, 934 single, dynamic RV outflow obstruction after, 610 single, in systemic disease patients, 837 Lymph node hyperplasia: See Giant lymph node hyperplasia Lymphadenopathy. hilar and mediastinal, after resection of carcinoma, 1251 Lymphangioma. giant tuberculous, 1279 Lymphatic system, abnormal, and sarcoidosis, 642 Lymphocyte subsets, peripheral blood , in lung cancer, 1673 Lymphocytes. lymphocytic alveolitis in crematorium worker, 617 subpopulation profiles in tobacco and marijuana smokers, 847 T Lymphocytes. circulating gamma/delta T cells in eosinophilic granuloma, 967 subsets in BALF in sarcoidosis, 1474 Lymphoma, involvement of lung, BAL in detection of. 458 mucosa-associated lymphoid tissue, 288 non-Hodgkin 's, BAL fluid profiles in, 514 Lyphoid tissue, mucosa-associated lymphoma of. 288

Macrophages, activation by N-acetylcysteine in COPD,BOO alveolar, antigen expression on, in HIV infection, 1324 alveolar, CD 14 expression on, in pulmonary sarcoidosis, 349 Magnesium sulfate, potentiates actions of terbutaline,701 Magnetic resonance imaging, diagnosis of platypnea after pneumonectomy, 931 in Castleman's disease of chest , 1608 in endobronchial lipoma, 1628 Malacoplakia, tracheal. 608 Maltase, acid, OSA in deficiency of, 947 Mandible, osteotomy for OSA, 278 retrognathia in Marfan 's syndrome, 1610 Marian's syndrome, pulmonary dysfunction in mandibular retrognathia In, 1610 Marijuana smoking, lymphocytic subpopulation profiles in smokers, 847 Markers, surface, expression of, on alveolar macrophages in HIV infec tions, 1324 Marketing, MRI investment and, 920 Mast cells, and histamine involvement in farmer 's lung disease , 1184 Mediastinal cyst. videoendoscopic removal of, 1254 Mediastinal neoplasms, traumatic hematoma, diagnosis of. 331, 373 Mediastinum. foreign body aspiration with migration in, 1923 lym phadenopathy after resection of carcinoma, 1251 lymphangioma extending to inguinal region from, 1279 CHEST/106/6/ JUNE 1994

1941

radiation therapy, thoracic artery graft occlusion after, 1881 sarcoidosis, ventilation-perfusion mismatch in, 1576 surgery, autologous blood transfusion for, 856 Medically underserved area, rationing medical care in the US, 984 Medicare, critical care, Clinton health plan, and, 1305 Medicine, academic nihilism, 1309 Membrane proteins, F vaccine , outer, preservation of pulmonary function by , 1545 Men, trainability of arms vs legs after MI, 262 Mercury , inhalation poisoning and lung injury , 613 Mesothelioma, malignant, of pleura, diagnosis, 321 pleural plaques and risk for, 8, 144 pleural multicystic proliferation, 295 Metabolism, actions of terbutaline potentiated by MgS0 4 , 701 hypermetabolism and efficiency of C02 removal in ARF, 1198 Metals, hard, eosinophilic lung reaction to, 1261 stent insertion for bronchostenosis after lung transplant, 343 stents in relapsing polychondritis, 864 Metastatic neoplasms, adrenal, from bronchogenic carcinoma, 1626 bilateral pneumothorax from, Heimlich valve treatment of, 1586 cardiac, from laryngeal carcinoma, 1304 diffuse lymphangitic, bronchorrhea from, 308 lung carcinoma, FOB in evaluation of, 454 malignant pleural effusion from prostatic adenocarcinoma, 1577 parasellar, panhypopituitarism from , 951 pleural, from breast adenocarcinoma, 1557 right atrial, of hepatocellular carcinoma, 945 skin, intravaseular bronchioloalveolar tumor with , 1882 Methacholine, bronchial responsiveness to, in diabetic, 644 challenge, partial 02 tension and lung mechanics during, 1905 comparison of industrial Provocholine and, 1095 eucapnic voluntatry hyperventilation compared as bronchoprovocation technique, 667 inhalation challenges, 1082 normal range of responsiveness , 661 Methicillin, nosocomial infections caused by S aurem resistant to, 826 Methotrexate, in asthma, perspectives on, 649 in steroid-dependent asthma, 117 Migraine, variant angina complicating ergot therapy, 1259 Minimally invasive techniques, localization of peripheral lung nodules, 1559 videoendoscopic removal of mediastinal cyst, 1254 Mitral valve, calcification of LV dysfunction , 383 Mortality, from bacteremic pneumococcal pneumonia, 1628 operative, factors affecting, in cardiac cachexia, 1347 risk in acute MI, 1687 role of selective digestive tract decontamination on, 1101

1942

Movement disorders, respiratory dysrhythmias in tardive dyskinesia, 203 respiratory dyskinesia, underrecognized, 1826 Mucociliary transport, in ICU patients, 237 Mucus, regional transport in airways obstruction, 1320 Multiple myeloma, pleural effusion in, 622 Mult iple sclerosis, control of breathing and respiratory muscle strength in, 1163 Muscle, smooth , proliferation in idiopathic pulmonary fibrosis, 339 Muscles, peripheral, hypophosphatemia and phosphorus depletion in, in RF, 1392 pharyngeal wall collapsibility and OSA, 1916 Muscular dystrophy, Duchenne's, inspiratory muscle training in, 475 Duchenne's, long-term NIPPV for, 337, 445 Myasthenia gravis , and small-cell lung carcinoma , 624 Mycobacterium av/um-Intracellulare complex , CT diagnosis of, 6, 49 Mycobacterium kansasll, infection after pulmonary malignancy, 325 Mycobacterium tuberculosis , infections, diagnosis of, 1116 Mycoplasma hominis. respiratory infection in marrow transplant recipient, 1891 Myeloid metaplasia, agnogenic, with hematopoiesis and fibrosis in lung, 1866 Myocardial infarction, cardioprotective effect of unstable angina prior to, 57 complicated by cardiogenic shock, 997 ECG in, 3 Culllain-Barre syndrome after, 1301 " infective," 1618 inferior, .coronary pathoanatomy in, 360 mortality risk and patterns of practice in, 1687 occult right ventricular, and pulmonary embolism, 1617 prognosis and sym ptoms I year after discharge from ER, 1442 pulmonary artery catheterization in, 1003 recurrent, polyarteritis nodosa presenting as, 1615 reestablishing coronary blood flow during, 574 thoracic artery graft occlusion after mediastinal radiation, 1881 trainabllity of arms vs legs after, 262 ventricular septal rupture after, with pulmonary edema, 1264 Myocardial ischemia, silent , detected by stress testing, 1009 Myocardial revaseularization, relationship between pleural and pericardial effusions after, 1748 Myxoma , fam ilial cardiac, 65 Interleukln-6 secreting, in LV, 962 left atrial, presenting as acute RF, 1282 left atrial, pulmonary venous flow in, 315 left ventricular, with 'torsades de pointes ,' 1876

Nasal obstruction, resistance in OSA, 1133 Nebulizers, dry powder inhalation device for albuterol, 1077 efficiency of bronchodilator aerosol delivery, 214 evaluation of MOl technique, 710 jet, characteristics of 18, 106

med ical personnel 's knowledge of and ability to use, 111 misuse of MOls in hospitalized patients, 715 pressurized MOl aerosols, 1621 Neoplasms : See also specific type, and specific body organ coagulation abnormalities in patients with, 1639 multiple primary, simultaneous occurrence of 3 lung cancers, 631 Neurofibromatosis, thoracic, with breathlessness, 589 Neuroma, acoustic , recurrent, and central alveolar hypoventilation, 949 Neuromuscular diseases, NPPV in, 337 Neutrophils, antineutrophil cytoplasmic antibodies in RA, 1590 erythromycin does not directly affect function of, 520 Nicotine, patch, with different counseling treatments, 524 Nifedipine, changes in distensibility of ascending aorta in coronary disease after, 1017 Nitric oxide, inhaled, reverses hypoxic pulmonary vasoconstriction, 1842 Nitroglycerin, paradoxic hypertension induced by, 1621 NK cells: See Killer cells, natural Noise, proliferation of alarms in the ICU, 1217 Norepinephrine, for hyperdynamic septic shock,7 Nose, lipid pneumonia from nasal use of Vaseline, 968 nasal prongs vs transtracheal catheter for 02 delivery, 1061 Nosocomial infections: See Cross infection

Obesity, effect on variables of signal-averaged ECGs,I357 respiratory drive in obese patients with sleep apnea, 1917 Occupational and environmental lung disease, work placement and worker fitness, 1564 Occupational diseases, eosinophilic lung reaction to metals, 1261 lymphocytic alveolitis in crematorium worker, 617 pulmonary function among cotton textile workers , 1713 spirometric impairments in long-term insulators, 175 Ofloxacin, pulmonary TB and , 1624 Oils, chronic aspirated motor oil in lung , 326 0ligo-2',5'-adenylate synthetase, in pulmonary sarcoidosis and fibrosis, 496 Omentum, pedicle to treat bronchopleural fistula ,957 Oscillometry, high-frequency ventilation for mercury inhalation poisoning, 613 Osteoarthropathy, clubbing of fingers in idiopathic pulmonary fibrosis, 339 Osteolysis, chylothorax in Gorham 's syndrome, 208 Osteom yelitis, sternal, after heart surgery, 1275 Osteoporosis, in female asthmatics receiving inhaled steroids , 1640, 1722 Osteotomy, mandibular, in OSA, 278 Outcome assessment, after in-hospital CPR, 991 Outpatient care: See Ambulatory care Oximetry, malfunction of oximeter, 975 pulse, monitoring in stable patients, 1630 Oxygen, conserving methods for adults, 248 extraction and cardiac index in the acutely ill, SubjectIndex, Volune 105(JanUIIIY.JInl,1994)

1190 orthodeoxia in amiodarone-induced pulmonar y damage, 965 transcutaneous partial tension during methacholine challenge, 1905 Oxygen consumption, nocturnal desaturations and snoring, 1637, 1759 of respiratory muscles in COPD, 790 transport characteristics of common ventilatory modes, 1798 uptake during incremental and maximal exercise, 1365 uptake for submaximal exercise in HF, 1693 Oxygen inhalation therapy, equip the units with sensors, 1924 interm ittent NPV and, in COPD, 95 low and high flow, effect on exercise tolerance, 1061 prognosis of hypoxemic patients receiving, 335, 469 should cardiac catheterization and coronary angioplasty patients receive? 727 Ozone, increase in ANF due to, 1551 Pacemaker, comparison of pacing modes in COPD,83 Pain, control after thoracotomy, 1907 Palate, uvulopalatopharyngoplasty for OSA, 155, 278 Papillary muscles, aortic valve fibroelastoma, 1885 Papilloma, recurrent respiratory, and bronchogenic squamous cell carcinoma, 1887 Parenteral nutrition, total , predictors of lipogenesis ind uced by, 553 Patients, unplanned extubations, 1496, 1804, 1808 Pectus excavatum : See Funnel chest Pediatrics, cardiac lCU, surface echocardiography in, 10 Pentamidine, cardiac arrhythmias during IV therapy with, 389 inhaled, in lung transplant recipients, 417 lobar levels in P carinI/ pneumonia, 53 reg ional deposition and ventilation during inhalation of, 396 Pentetic acid, 99mTC, aerosol characteristics of synthetic surfactant and , 1765 Percussion, auscultatory, rapid diagnosis of pulmonary abnormalities in HIV , 402 che st, arrhythmia during, 1303 intrapulmonary ventilation using , vs chest physiotherapy, 1789 Periarteritis nodosa , presenting as recu rrent MI, 1615 Pericardial effusion, relationship with pleural effusion after myocardial revascularization , 1748 Pericarditis, constrictive, platypnea related to, 636 S aurem, in HIV-infected patients, 615 Peritoneal dialysis, LV d ysfunction in end-stage renal disease patients on, 383 Peterson, Sylvia J., acclaimed executive editor, 1633 Petrolatum, lipid pneumonia due to nasal application of, 968 Petty, Thomas L., 36th Aspen lung conference, Mar supp, 43S-132S Phantom limb, phantom angina, 1271 Pharynx, uvulopalatopharyngoplasty for OSA, 155,278 wall collapsibility and OSA, 1916 Phenotype, a.-antitrypsin, and asthma, 1905

Phenytoin, toxicity and hypoalbuminemia, 602 Phosphorus, depletion in respiratory failure due to COPD, 1392 Phrenic nerve, fatal bilateral injury, 1268 injury, 1618 Physical therapy, cardiopulmonary physiology and, discordance between, 322 chest, vs intrapulmonary percussive ventilation , 1789 Physicians, estimation of FEV I in acute COPD, 1709 perspective on life-sustaining devices in home care, 1448 practice patterns, academic nihilism, 1309 primary care, what is it? 1633 Pituitary neoplasms, parasellar metastasis from lung cancer, 951 Plasma, for ABC analysis in leukemia, 954 Plasminogen activator, tissue, for life-threatening pulmonary embolism, 1291 Platypnea: See Dyspnea Plethysmography, impedance, effect of PPV on, 1813 Pleura, agnogenic m yeloid metaplasia with extramedullary hematopoiesis and fibrosis, 1866 bronchopleural fistula after pneumonectomy, 597 bronchopleural fistula in Boerhaave's syndrome, 964 fibrosis ind uced by asbestos , 1312, 1370 incomplete fusion , bilateral pneumothorax after needle biopsy, 627 intrapleural urokinase in loculated effusions , 868 multicystic mesothelial proliferation, 295 plaques, bronchial carcinoma and mesothelioma , 8,144 raised adenosine deaminase, 1911 SVC syndrome caused by right apical tense bulla, 611 TB and HIV infection, 1338 thickening in pleural TB , 1296 treatment of bronchopleural fistula, 1879 Pleural effusion, ADA activity in Q fever pneumonia with, 648 am ylase concentrations in, 1625 distinguishing between exudates and transudates, 1912 efficacy of doxycycline for pleurodesis in, 1743 idiopathic, in bronchogenic carcinoma, 1663 in multiple myeloma, 622 loculated, intrapleural urokinase for , 868 loculated, transcatheter urokinase for, 1874 malignant, from prostatic adenocarcinoma, 1577 malignant, management of, 1 postural changes in fluid constituents, 1458 pulmonary coccidioidomycosis with, 918 relationship with pericardial involvement af ter myocardial revascularization, 1748 talc slurry for pleurodesis, 1906 transudative and exudative, separation of, 974 Pleural neoplasms, diagnosis of malignant mesothelioma, 321 invasive thymoma, panpleuropneumonectomy for, 1884 metastatic, from breast adenocarcinoma, 1557 Pleurisy, with dyspnea and hemoptysis, 1557 Pleuritis, chest pain in pulmonary coccicioidomycosis with pleural effusion, 918

Pleurodesis, efficac y of doxycycline for, 1743 talc, during videothoracoscopy for PCP, 314 talc slurry for, 1906 with polidocanol in pigs, 908 Plombage, complications, treatment of, 1622 Lucite sphere thoracoplasty and lung carcinoma, 1622 Pneumatosis intestinalis, after lung transplantation,929 Pneumoconiosis, hard metal, 1261 Pneumocystis carinll, localized growth in HIVinfected patients, 1285 Pneumocyslis carinl/ pneumonia: See Pneumonia Pneumonectomy, amiodarone and development of ARDS after, 1635, 1642 assessment of operative risk, 654, 753 bronchopleural fistula after, 957 complications of, MUCA as predictor of, 1454 exercise testing in evaluating high-risk patients for, 1617 panpleuro-, for pleural dissemination of invasive thymoma, 1884 platypnea after, 931 Pneumonia, A actinomycetemcomllans, with possible embolization, 645 accuracy of portable chest radiography in diagnosis of, 885 bacterial, pulmonary gangrene as complication of, 567 early aggressive surgical management of parapneumonic empyemas, 832 early onset in trauma patients, 224 identification of low-risk hospitalized patients with, 1109 legionnaire's, lymphocytic interstitial pneumonitis after, 325 lipid, exogenous, from nasal use of Vaseline, 968 lipid, idiopathic, prednisolone treatment, 956 pneumococcal, deaths from , 1628 pneumonitis associated with therapy for hepatitis C, 939 Q fever, with pleural effusion , 648 severe community-acquired, 1487 stomach is not source of, in the ICU, 878 syphilitic pneumonitis in HI V-Infected patient,629 Pneumonia, interstitial: See Pulmonary fibrosis Pneumonia, Pneumocystis carinl/ arrhythmias during IV pentam idine therapy for , 389 induced sputum analysis in diagnosis of, 1770 inhaled pentamidine in lung transplant rec ipi ents, 417 lobar pentamidine levels in, 53 regional deposition and ventilation during inhalation of pentamidine for, 396 sputum induction vs BAL in diagnosis of. 650. 816 talc pleurodesis during videothoracocoscopy for, 314 ultrastructural observation of P carinll in BAL fluid in, 1342 Pneumonitis, interstitial: See Pulmonary fibrosis Pneumoperitoneum, associated with suicidal hanging. 1300 Pneumothorax, bilateral. after needle biopsy. 627 bilateral metastatic, Heimlich valve treatment of. 1586 determining the size of, 1908

CHEST/105/6/ JUNE 1994

1943

iatrogenic, significance of, 980, 1147 in AIDS, doxycycline pleurodesis for, 823 pleural metastases as cause of. 1557 risk not increased by OLD in needle biopsy, 1705 simultaneous bilateral spontaneous, 1142 talc pleurodesis during videothoracoscopy for PCP related to, 314 vocal cord paralysis due to, 1297 Poisoning, mercury inhalation, and lung injury, 613 Polidocanol, pleurodesis with , in pigs, 908 Poliomyelitis, dyspnea years after, 777 Polyarteritis nodosa : See Periarteritis nodosa Polychlorinated biphenyls, binding proteins, ontogeny of , 17 Polychondritis, relapsing, metallic stents in, 864 Polymerase chain reaction, in d iagnosis of M tuberculosts infections, 1116 Positive airway pressure, respiratory muscle rest using BiPAP ventilation, 1053 Positive airway pressure, continuous changes in work of breathing during, 860 nasal , in SAS, 429 survival in OSA after use of, 155 Positive expiratory pressure, effects during exercise in COPD, 782 Positive pressure respiration, effect on impedance plethysmography, 1813 intermittent, nasal, in Duchenne's MD, 337, 445 intermittent, nasal. in respiratory insufficiency, 100 nasal , for acute respiratory failure, 229 nocturnal nasal. short-term, in OSA and hypercapnia, 434 Postoperative complications, alleviating postthoracotomy pain, 1299 bronchial stenosis after lung transplant, 934 bronchopleuralfistula after pneumonectomy, 957 early treatment of sepsis after cardiac surgery, 76 fatal phrenic nerve injury following heart surgery, 1268 gossypibomas mimicking echinococcal cyst of lung, 284 in endobronchial laser resection, 1668 of lung resection , MUGA as predictor of. 1454 pain control after thoracotomy, 1907 phrenic nerve injury, 1618 platypnea after pneumonectomy, 931 pleural and pericardial, after myocardial revascularization, 1748 pneumatosis intestinalis and CMV infection after lung transplant, 929 pulmonary, preoperative respiratory muscle training and, 1782 sternal osteomyelitis after cardiac surgery, 1275 Posture, antalgic positions in alleviating postthoracotomy pain, 1299 arrhythmia during postural drainage, 1303 changes in pleural 8uid constituents, 1458 head position as factor in endotracheal tube resistance, 1794 normal pulmonary function and blood 80w values sitting or supine, 501 pronus angina, 1632 Potassium : See Hypokalemia Prednisolone, plasma levels of leukotriene E4 in asthma and effect of. 1038 treatment of idiopathic lipoid pneumonia, 956

1944

Preexcitation syndrome, ventricular, concertina-like phenomenon in, 937 Pregnancy, after curative therapy for advanced lung cancer, 307 cocaine use and sarcoid cardiomyopathy, 303 critical illness in, 1915 Pressure, high inspiratory, causes of hypoventilation with, 550 peak airway, why the fuss? 242 Primary health care, physician, what is it? 1634 Professional competence, interrater and intrarater reliability in evaluating MDIs, 710 scopist var iabil ity in diagnosis of lung cancer by FOB, 1658 Prognosis, after negative pulmonary angiogram, 1257 in sarcoidosis, are antiphospholipid antibodies a factor in? 1179 of lung cancer, sec Ag in, 773 of severely hypoxemic patients, 335, 469 one year after discharge from ER, 1442 peripheral blood lymphocyte subsets and survival in lung cancer, 1673 prolonged survival in malignant airway obstruction, 767 status following in-hospital CPR, 991 survival in endobronchial laser resection, 1668 survival in PTCA patients with LV dysfunction, 733 Propafenone, oral , for recent-onset atrial fibrillation, 1013 Prostacyelin, in septic shock, 1504 Prostaglandin EI , extending lung preservation after infusion of, 255 Prostatic neoplasms, adenocarcinoma, malignant pleural effusion from, 1577 Proteins, persistence of RSV genome and, after bronchiolitis, 1848 Provocation tests: See Bronchial provocation tests Provocholine, comparison of industrial methacholine and, 1095 Pseudomonas aeruginosa, pulmonary infection, preservation of pulmonary function in, 1545 Pseudomonas cepacia, empyema necessitatis after lung transplant, 1888 potential of nosocomial transmission of, 1630 Public health, tuberculosis and, 326 Pulmonary alveolar proteinosis, primary, lung lavage in, 1605 Pulmonary alveoli, diffuse hemorrhage in marrow transplant recipient , 1891 hemorrhage associated with ANCA in RA, 1590 Pulmonary and critical care pearls, cough, fever and cavitating pulmonary lesions, 591 dyspnea, cough, and ILD, 265 dyspnea, pleurisy, and hemoptysis, 1557 fever, cough and pleuritic chest pain, 918 hilar and mediastinal lymphadenopathy, 1251 recurrent asthma despite corticosteroid therapy, 1855 Pulmonary artery, catheter, use in critical care, 643 catheterization in MI, 1003 catheterization in the ICU , 874 multiple peripheral branch stenosis, 1294 muscular, perivascular fibrosis of, in COPD, 973 noninvasive hemodynamics in alveolar proteinosis, 1605 prognosis after negative angiogram , 1257

right, origin from ascending aorta, 1280 staphylococcic endarteritis with aortopulmonary fistula, 1631 Pulmonary capillaries, normal values for blood 80w in, SOl Pulmonary complications, after thoracotomy for lung carcinoma, 760 of lung resection, MUGA as predictor of, 1454 postoperative, preoperative respiratory m uscle training and, 1782 Pulmonary diffus ing capacity, calculating, 4 methods compared, 594 single breath, for CO in asthma, 1426 single exhalation, normal values for, 501 Pulmonary diseases, and extrapulmonary involvement in system ic sclerosis, 489 aspergillosis d iagnosed by antigen in urine, 1304 aspergillosis in AIDS patients, 37 BAL profiles in, 514 cavitary coccidioidomycosis with fungus ball formation, 412 coccidioidomycosis with pleural effusion, 918 comprehensive outpatient rehabilitation, 1046 exercises in preventing, after coronary surgery, 741 gangrene, complication of pneumonia, 567 gossypibomas mimicking echinococcal cyst, 284 hepatopulmonary syndrome, 1528 histiocytosis X, 265 infection caused by P aeruglnosa, preserving pulmonary function in, 1545 involvement in hypereosinophilic syndrome, 656

lung function impairment in sarcoidosis, 349 M avlum complex and women, 6 multidisciplinary rehabilitation program, 640 nosocomial infections caused by methicillinresistant S aureus, 826 possible marker, erythrocytic glutathione in CF,1470 rapid diagnosis of, in HIV patients, 402 relation of sleep complaints to respiratory symptoms, 151 re versible damage induced by amiodarone, 965

sarcoidosis, 0Iigo-2',5 '-adenylate synthetase in, 496 secondary to manidbular retrognathia in Marfan 's syndrome, 1610 single lung transplant in patients with systemic disease, 837 work placement and worker fitness, 1564 Pulmonary diseases, chronic obstructive: See also Asthma; Bronchitis; Emphysema comparison of pacing modes in, 83 comparison of 3 drugs for, 1089 distinguishing between asthma and, 1042 " early," pulmonary rehabilitation of, 1636 effects of PEP during exercise in, 782 effects of theophylline withdrawal in, erratum, 1924 hypophosphatemia and phosphorus depletion in RF due to, 1392 intermittent NPV and 02 therapy in, 95 ipratropium and albuterol combined for , 1411 low-dose almitrine bismesylate for hypoxemia in, 1383 macrophage activation by N-acetylcysteine in, 806

SubjectIndex, Volume 105 (January.Jt.nl, 1994)

multidisciplinary rehabilitation program, 640 nasallPPV in, 100 NPV improves respiratory function in, 87 oxygen consumption of respiratory muscles in, 790 perivascular fibrosis of muscular pulmonary arteries in, 973 physician estimation of FEV 1 in acute exacerbation of, 1709 prognosis of severely hypoxemic pat ients with , 335, 469 pulmonary hemodynamics in, 1377 reanalysis of 12-minute walk in, 163 respiratory muscle rest using BiPAP ventilation in, 1053 risk of pneumothorax not increased by, in needle biopsy , 1705 severe, life expectancy in, 335 vocal cord paralysis due to pneumothorax in, 1297 weaning from mechanical ventilation in, 1204 Pulmonary edema, associated with radiocontrast material, 641 increase in ANF in lungs, heart and circulatory system owing to ozone , 1551 management of respiratory failure due to, 229 noncardiac, complicating verapamil overdose, 606 postinfarction left-sided unilateral, 1264 Pulmonary embolism, fatal , in spinal cord injury , 853 lethal, in patient with vena caval filter, 312 life-threatening, with heart thrombus, 1291 massive emboli, rapid visualization of, 888 occult right ventricular infarction with, 1617 prognosis after negative angiogram, 1257 unsuspected thromboembolism, impact of, 986 unusual complication of CVC, 905 Pulmonary eosinophilia, idiopathic pneumonia, 1462 inhaled corticosteroids in, 1913 Leffler 's syndrome secondary to crack cocaine, 1599 reaction to aluminum and hard metal, 1261 Pulmonary fibrosis, agnogenic myeloid metaplasia with, 1866 chemotherapy- induced, lung transplant for, 310

chlorambucil-associated pneumonitis, 634 diffuse pneumonitis induced by carmustine, 1602 dyspnea, cough, and lLD, 265 exercise limitation in interstitial disease , 183 idiopathic, fibrotic changes in lung in, 339 lymphocytic interstitial pneumonitis after legionnaire's pneumonia, 325 oligo-2 ',5'·adenylate synthetase in, 496 Pulmonary function, among cotton textile workers, 1713 assessment of operative risk in lung resection, 654, 753 before surgery for pectus excavaturn, 1646 effect of surfactants on, after CPB, 421 effects of biofeedback-assisted breathing retraining on, in CF, 23 impairment in pulmonary sarcoidosis, 349 in asthmatics after whole-body exposure to cold and wind, 1728 in COPD, NPV improves, 87 prechallenge, normal range of methacholine responsiveness in relation to, 661

Pulmonary function tests, clinical problems in, calculating diffusing capacity, 594 Pulmonary gas exchange, almitrine bismesylate for hypoxem ia in COPD, 1383 effect of surfactants on, after CPB, 421 single breath diffusing capacity for CO in asthma, 1426 Pulmonary hypertension: See Hypertension, pulmonary Pulmonary manifestations, in Wegener's granulomatosis, 509 Pulmonary medicine, academic physicians, starting a career, 1858 Pulmonary neoplasms: See also Carcinoma advanced, pregnancy after curative therapy for , 307 analysis and typing of, 138 and Lucite sphere plombage thoracoplasty, 1622 bronchorrhea from diffuse lymphangitic metastasis to, 308 cavitating Hodgkin 's disease, 591 congenital predisposition to, evaluation of, 449 electrical impedance analysis for diagnosis of mass, 1679 endobronchial aspiration in diagnosis of small-cell carcinoma, 1151 endobronchial spread of bronchoalveolar cell carcinoma, 1627 env ironmental asbestosis complicated by, 1593 fatal hypercoagulability and TlA in patients with , 1639, 1683 intravascular bronchioloalveolar tumor with skin metastasis, 1882 left upper lobe mass and reticular-nodular infiltrate, 1864 localization of nodules during thoracoscopic resection, 1467 localization of peripheral nodules, 1559 lymphomatous, detection by BAL, 458 metastatic carcinoma, FOB in evaluation of, 454 metastatic pneumothorax in, Heimlich valve treatment of, 1586 multiple chondromata causing neonatal respiratory distress, 301 multiple nodules and NK cell granular lyrn phocyte proliferative disorders, 1893 myasthenia gravis with small-cell carcinoma, 624 panhypopituitarism from metastasis from, 951 plasma cell granuloma, corticosteroid therapy , 1574 primary, M kansas/i infection after, 325 pulmonary complications after thoracotomy for, 760 radiation therapy in squamous cell carcinonrna, 132 scopist variability in diagnosis of, by FOB, 1658 simultaneous occurrence of 3 primary cancers,631 squamous cell carcinoma antigen in diagnosis and prognosis of, 773 Pulmonary sequestration: See Bronchopulmonary sequestration Pulmonary surfactants, aerosol characteristics of DTP A and, 1765 exogenous, effect on lung function after CPB, 421 exogenous, therapy in ARDS, 1310

porcine, in ARDS, 195 synthetic, for ARDS, 1263 Pulmonary vein, anomalous drainage, scimitar variant, 292 Bow in left atrial myxoma, 315 normal drainage, scimitar sign with, 294 Pulmonary vessels, bed, vasoconstrictor effects of angiotensin Il on, 1360 hypoxic vasoconstriction, inhaled NO reverses, 1842 lesions in thromboembolic pulmonary hypertension , 1619 resistance in emphysema, 798 TEE diagnosis of AV malformation of, 1604 vasodilators, different vasoactive mechanisms of, 1920 Q fever, pneumonia, with pleural effusion, 648 Quadriplegia, failure to wean from ventilator in patients with, 1292 Quality of life, before and after lung transplant. 9Il Questionnaires. factors related to SAS in sleep clinic patients. 1753 Radial artery. pressure during anesthesia. 69 Radiation injuries. thoracic artery graft occlusion following mediastinal radiation. 1881 Radiology. interventional. concerns, 643 Radionuclide imaging. aerosol characteristics of 99mTC-pentetic acid and Exosurf, 1765 MUGA as predictor of complications of lung resection, 1454 Radiotherapy. for malignant airway obstruction . prolonged survival after, 767 in squamous cell lung carcinoma. 132 Receptors. serum levels of Fcsftll in asthma.

681 Reflex, cough. swallowing and. after stroke, 1623 Rehabilitation. comprehensive outpatient pulmonary. for dyspnea. 1046 multidisciplinary pulmonary program. 540 pulmonary. of "ea rly" COPD, 1636 Relaxation techniques. passive. to evaluate respiratory mechanics, 1171 Respiration, control of, and respiratory muscle strength in MS, Il63 drive in obese patients with sleep apnea, 1917 dysrhythmias in tardive dyskinesia. 203 load compensation during hypercapnic ventilatory response . 1399 mechanics. and restrictive respiratory dlsorders, Il71 rapid shallow breathing and extubation outcome, 540 reduced exercise tolerance, evaluating, 1122 regional, during inhalation of pentamidine, 396 remote recording of sleep-related disorders of, 160 sleep-disordered breathing. unattended studies of, 1637 sleep-disordered, diagnosis and treatment of, 1306 sleep-disordered. snoring and nocturnal 02 desaturations, 1637, 1759 symptoms, relation of sleep complaints to. 151

CHEST /105/6/ JUNE 1994

1145

Respiration, artificial: See also specific type, as Positive pressure respiration asthma requiring, 891 building consensus on use of, erratum, 648 characteristics of common modes, 1798 efficiency of bronchodilator aerosol delivery, 214 HFOV, for mercury inhalation poisoning, 613 high-frequency, in pediatric respiratory failure, 652 intermittent NPV and 02 therapy in COPO, 95 intrapulmonary percussive, vs chest physiotherapy, 1789 inverse ratio. in respiratory failure, 646 nasal mask ventilation for respiratory failure, 441 negative pressure, improves respiratory function in COPO, 87 noninvasive respiratory aids, 1230, 1538 pressure support, estimation of triggering work of breathing, 1836 respiratory system resistance in critically ill during, 219 resting energy expenditure in ventilated patients,554 weaning from , in COPO, 1204 Respiratory distress syndrome, neonatal, multiple pulmonary chondromata as cause of, 301 Respiratory distress syndrome, adult almitrine for hypoxemia in, 1579 amiodarone and development of, 1635, 1642 can heparin cause? 1266 effects of N-acetylcysteine on development of, 190 exogenous surfactant therapy in, 1310 fatal hypercoagulability and , in lung cancer patients, 1639, 1683 hereditary angioedema with, 1898 late, corticosteroid rescue treatment in, 1516 porcine surfactant in, 195, 1310 pulmonary involvement in hypereosinophilic syndrome, 656 role of coagulation system in, 268 synthetic surfactant for, 1263 typhoid fever with , 1873 urine hydrogen peroxide during, 232 Respiratory failure, acute, hypermetabolism and efficiency of C02 removal in, 1198 acute, left atrial myxoma presenting as, 1282 acute, management of, 229 acute, nasal mask ventilation for, 441 chronic, nasal IPPV in, 100 corticosteroid rescue treatment in late AROS with , 1516 hypophosphatemia and phosphorus depletion in, 1392 hypoxemic, following thrombolytic therapy for hemothorax, 1595 lung transplants after prior bone marrow transplants, 327 occlusion of bronchus by expanding foreign bod y, 1600 peak airway pressure , why the fuss? 242 pediatric, high-frequency ventilation in, 652 severe, inverse rat io ventilation in, 646 Respiratory hypersensitivity, role of C albicans in chronic pneumonitis, 317 Respiratory medicine, how is it growing in Europe? 330 Respiratory muscles, dyskinesia, underrecog-

1948

nized ,1826 hypophosphatemia and phosphorus depletion in, in RF, 1392 inspiratory, tra ining in MO patients, 475 noninvasive aids, 1230, 1538 oxygen consumption of, in COPO, 790 preoperative training, 1782 rest using BiPAP ventilation in COPO, 1053 strength in MS, and control of breathing, 1163 strength in chronic heart failure, 355 Respiratory sounds, during histamine challenge, 122 Respiratory syncytial viruses, genome and protein , persistence of, after bronchiolitis, 1848 Respiratory therapy, medical personnel and use of inhaling devices, III Respiratory tract, isolates of Hafn/a aloe! in a hospital, 1098 resistance and expired capnogram in the critically ill, 219 upper, stomach not source for colonization of, 878 Respiratory tract diseases, restrictive, relaxation technique to evaluate respiratory mechanics in, 1171 Respiratory tract infections, M hominis, in bone marrow transplant recipient, 1891 recurrent, and airway obstruction, 1066 selectivedigestive tract decontamination and, 1101 Rest, energy expenditure at , in ventilated patients, 544 Resuscitation, cardiopulmonary, biphasic extrathoracic, 842 in-hospital CPR , status following, 991 Retrognathism , mandibular, in Marfan's syndrome, 1610 Review, congestive heart failure, 897 hepatopulmonary syndrome, 1528 legionnaires' disease, 1817 noninvasive respiratory muscle aids, 1230, 1538 oxygen conserving methods for adults , 248 peak airway pressure , 242 pulmonary gangrene, 567 reestablishing coronary blood Bow during Ml,574 respiratory dyskinesia, 1826 selective decontamination of digestive tract, 978, 1221 Risk, evaluating high-risk patients for resection , 1617 mortality, in acute Ml, 1687 Risk factors, affecting operative mortality in cardiac cachexia , 1347 for early onset pneumonia in trauma patients, 224 operative, assessment in lung resection, 654, 753 Roentgenogram of month, breathlessness with bumps and lumps, 589 dyspnea and tracheal mass, 1555 large air-filled cyst, 253 left lung atelectasis in smoker, 1833 massive hemoptysis years after repair of aortic coarctation, 1249 unusual complication of CVC, 905 Roentgenography, abnormalities in long-term insulators, 175 lateral radiographs in the ICU, 560 of chronic aspirated motor oil in lung, 326 Rupture, of esophagus, Boerhaave's syndrome,

964

Salbutamol, dose-effect relationship of, in asthma, 1738 Saline : See Sodium chloride Salmeterol, inhaled, in asthma, 1032 Sarcoidosis, abnormal lymphatics and, 642 antiphospholipid antibodies a prognostic factor in? 1179 BAL Buid profiles in, 514 HIV infection and, 1299 lymphocyte subsets in BALF in, 1474 mediastinal, ventilation-perfusion mismatch in, 1576 of middle ear , 1582 pulmonary, lung function impairment in, 349 pulmonary, 0ligo-2 ',5'-adenylate synthetase in, 496 sarcoid cardiomyopathy in pregnancy, 303 Sarcoma, Kaposi's, endobronchial occlusion by, 1581 Kaposi's, endobronchial, in HIV-infected individuals, 1314 Scimitar syndrome, normal pulmonary venous drainage in, 294 variant, 2 cases, 292 Scleroderma, systemic, pulmonary and extrapulmonary involvement in sclerosis, 489 system ic, small airways dysfunction, and bronchial hyperreactivity, 1922 Sclerosis, systemic: See Scleroderma, systemic Self administration, of multidose dry powder inhalation device for albuterol, 1077 Self-injurious behavior, unplanned extubations, 1496, 1804, 1808 Serum albumin, phenytoin toxicity and hypoalbuminemia, 602 Sex factors , mortality risk and , in acute MI,I687 Shock, cardiogenic, ruptured tricuspid valve chordae tendinae as etiology for, 1286 cardiogenic, treatment of Ml complicated by, 997 septic, evaluation of definitions of sepsis, 970 septic, prostacyclin in, 1504 septic, sepsis syndrome after BAL, erratum, 648 Skin neoplasms , metastasis, intravascular bron chioloalveolar tumor with, 1882 Sleep, effects of abstinence from smoking on sleepiness and, 1136 heart rate variability in snorers during, 1300 Sleep apnea syndromes, factors related to in sleep clinic patients, 1753 nasal CP AP in, 429 respiratory drive in obese patients with, 1917 Sleep apnea syndromes, obstructive four-channel recordings in diagnosis, 230 heart rate variability in snorers with, 1300 hypothyroidism and , 1296 in acid maltase deficiency, 947 nasal resistance in, 1133 pharyngeal wall collapsibility and, 1916 severe, short-term NIPPV in, 434 survival after uvulopalatopharyngoplasty, 155 treatment of, 278 Sleep disorders, breathing, diagnosis and treatment of, 1306 breathing, unattended studies of, 1637 breathing, what is hypopnea, anyway? 426 relation to respiratory symptoms, 151 remote recording of respiratory disorders re-

Subject Index, Volume 105 (January.June, 1994)

lated to. 160 snoring and nocturnal 02 desaturations, 1637. 1759 Smoking. abstinence from , effects on sleep and sleepiness. 1136 dyspnea. cough and ILD in a smoker, 265 left lung atelectasis in smoker. 1833 lymphocytic subpopulation profiles in tobacco and marijuana smokers, 847 nicotine patch and different counseling treatments, 524 pleural plaques. bronchial carcinoma and mesothelioma, 8, 144 spirometric impairments in insulators relation to. 175 Snoring. heart rate variability during sleep in snorers, 1300 nocturnal 02 desaturations and , 1637. 1759 Sodium chloride, effect of sodium cromoglycate in airway narrowing induced by saline. 673 Sodium cromoglycate: See Cromolyn sodium Sodium hypochlorite, inhalation of hydrochloric acid and, persistent asthma after, 1895 Specialties, critical care board examination resources , erratum, 648 Spinal cord injuries, cervical, bronchial hyperresponsiveness after, 1073 fatal pulmonary embolism in, 853 Spirometry, impairments in long-term insulators, 175 Spleen. left upper lobe mass and diffuse reticular-nodular infiltrate. 1864 Sputum, bronchorrhea in diffuse Iymphangitic metastasis. 308 hygiene before expectoration of, for bacterial culture, 1923 induced, in diagnosis of PCP, 1770 induction vs BAL in diagnosis of PCP. 650, 816 Staphylococcal infections. aortic root endocarditis, 1631 Staphylococcus aureus. methicillin-resistant, nosocomial infections caused by, 826 pericarditis in HIV-infected patients, 615 Stents, metal Wallstent insertion for bronchostenosis after lung transplant, 343 metallic. in relapsing polychondritis, 864 subglottic tracheal, external fixation of. 1653 Sternocostal joints, transient swelling of costochondral and sternal region in infants, 29 Sternum. osteomyelitis due to A [umigatus, 1275 transient swelling in region of. in infants. 29 Stomach, not source for infection in ICU patients.878 Stroke : See Cerebrovascular disorders Subcutaneous emphysema. spontaneous or iatrogenic? 321 Substance abuse. Chlamydia pneumoniae infection in former injection-drug users. 812 cocaine, in pregnancy. sarcoid cardiomyopathy due to. 303 Leffler's syndrome secondary to crack cocaine, 1599 Suicide. attempted, pneumoperitoneum associated with hanging. 1300 Surfaetants: See Pulmonary surfactants Swallowing: See Deglutition Syncope, cardiac metastasis presenting as. 1304 diagnosis and management. 1246 Syphilis , syphilitic pneumonitis and HIV infection. 629

Tachycardia, A-V node re-entry of common variety, 1869 ventricular, cough-induced nonsustalned, 1583 Talc. pleurodesis during videothoracoscopy for PCP. 314 slurry for pleurodesis, 1906 Teaching, starting an academic career, 1858 Technology, assessment of life-sustaining devices in home care. 1448 high-technology home care, 4 Temperature. in stability of blood gases, 1904 Terbutaline, cardiovascular and metabolic actions of, 701 powder in bronchial obstruction. 697 Tetracycline, pleurodesis for malignant pleural effusions. 1 Thallium, stress testing. symptoms of silent ischemia detected by. 1009 Theophylline, oral . vs inhaled lpratropium, in combined therapy for COPD, 1089 Thoracic artery, graft occlusion after mediastinal radiation. 1881 Thoracoplasty, Lucite sphere plombage, and lung carcinoma, 1622 Thoracoscopy, forum , dialogue continues. 1909 localization of peripheral lung nodules for surgery via, 1559 resection of pulmonary nodules during, 1467 video , for PCP, talc pleurodesis during, 314 videoendoscopic removal of mediastinal cyst, 1254 Thoracotomy, antalgic positions in alleviating pain after, 1299 for lung carcinoma, pulmonary complications after, 760 pain control after, 1907 Thorax: See Chest Thrombocytopenia, heparin-associated, can ARDS be caused by similar mechanism? 1266 Thromboembolism, chronic pulmonary hypertension with, 1619 unsuspected pulmonary, impact of, 986 Thrombophlebitis. selecting a vena cava device. 1632 Thrombosis. heart. life-threatening pulmonary embolism with, 1291 inducing activity with fatal hypercoagulability, 1639, 1683 urokinase for dissolution of massive clot, 953 Thymoma, invasive, pleural dissemination of, 1884 malignant, 941 Tidal volume , rapid shallow breathing and extubation outcome, 540 Tomography, computed chest. is it performed too often? 647 diagnosis of M av/um-/ntrace/lularecomplex, 649 evidence of adrenal gland metastases, 1626 high-resolution, bronchoscopic correction in hemoptysis, 982, 1155 in endobronchial lipoma. 1628 measurement of RV volume in explanted hearts, 585 Torsades de pointes, induced by erythromycin, 368 left ventricular myxoma with, 1876 Trachea. aspirates in bronchopulmonary dysplasia, polychlorinated biphenyl BP in, 17 endoscopic classification of TB, 318 external fixation of subglottic stents, 1653 malacoplakia, 608 occlusion , 1921

tracheobronchial obstruction as cause of hypoventilation, 550 Tracheal neoplasms, chondrosarcoma with dyspnea.l555 Tracheostomy. laceration of endotracheal tube cuff during, 644 pulmonary aspiration in ventilated patients with, 563 Transplantation: See Bone marrow transplantation; Heart transplantation; Lung transplantation Tricuspid valve, ruptured chordae tendinae, TEE diagnosis of, 1286 Tuberculosis, among immigrants, 1911 BAL Buid profiles in, 514 endobronchial, 1910 giant tuberculous lymphangioma, 1279 rnultidrug-resistant, 45 multiple drug therapy, hepatotoxicity of acetaminophen in, 408 normalization of CD4+ T-Iymphocyte depletion in, 1355 pleural. and HIV infection, 1338 pleural. pleural thickening in, 1296 polymerase chain reaction in diagnosis of, 1116 public health and, 326 pulmonary, and oBoxacin, 1624 raised pleural ADA, does it mean? 1911 tracheobronchial, endoscopic classification of,318 treating plombage complications, 1622 Typhoid, with ARDS, 1873 Ultrasonography, intravascular, in visualizing massive pulmonary emboli, 888 Urine, false-positive results for Aspergillus antigen in, 975 hydrogen peroxide during ARDS, 232 pulmonary aspergillosis diagnosed by antigen in, 1304 Urokinase, endobronchial. for dissolution of massive clot, 953 intrapleural, for loculated effusions. 868 transcatheter intrapleural, for loculated pleural effusion, 1874 Uvula, uvulopalatopharyngoplasty for OSA, 155,278 Vaccines, outer membrane protein F. preservation of pulmonary function by, 1545 Vascular resistance, amrinone effects on, 62 pulmonary, in emphysema, 798 Vasoconstriction, effects of angiotensin 11 on pulmonary vascular bed, 1360 hypoxic pulmonary, inhaled NO reverses, 1842 Vasodilators, pulmonary. different vasoactive mechanisms of, 1920 Veins, central. resection for invasive cutaneous Aspergillus infection, 1283 Vena cava. inferior. filter, lethal pulmonary embolism in patient with , 312 . Vena cava, superior foreign body aspiration with penetration of, 1923 scimitar variant, 292 syndrome caused by right apical tense bulla , 611 syndrome com plicating malignant thymoma, 941

CHEST /105/6/ JUNE 1994

1947

Venae cavae, selecting a device. 1632 Ventilation. mechanical: See Respiration. artificial Ventilation-perfusion ratio, mismatch in mediastinal sarcoidosis, 1576 Ventilator weaning. failure, chest tubes and lung entrapment. 1292 in COPD. 1204 prolonged mechanical ventilation, 534 rapid shallow breathing and extubation outcome . 540 RV function during, after CABG, 1352 unplanned extubations, 1496, 1804. 1808 Ventilators. back to the future, 983 bronchitis patients assisted by. ipratropium bromide in. 1511 negative pressure , and ~ therapy in COPD, 95 negative pressure, improves respiratory function in COPD, 87 oxygen conserving methods for adults. 248 Ventricle. preexcitation syndrome, concertinalike phenomenon in. 937 Ventricle. left aneurysm rupture, 1302 dysfunction, mitral valve calcification in. 383 function after coronary angioplasty. 57

1848

hypertrophic. myxoma in, 962 remodeling in valvular aortic stenosis. 1273 severe dysfunction. survival after PTCA in patients with. 733 Ventricle right biopsy in diagnosis of coronary atheroembolism.632 coronary pathoanatomy in acute inferior MI. 360 double outlet . 290 dynamic outflow obstruction, 610 function during respirator weaning after CABG.I352 measurement of volume in expIanted hearts, 585 Ventricular fibrillation, after exercise-induced anaphylaxis. 620 Ventricular septum. postinfarction rupture. pulmonary edema in. 1264 Verapamil, overdose. noncardiac pulmonary edema complicating. 606 Viruses. recovery from BAL 8uid, 1775 Vital capacity, forced, distinguishing between

asthma and COPD. 1042 Vocal cord paralysis, due to pneumothorax. 1297 Walking. reanalysis of 12-minute walk in COPD.I63 Wegener's granulomatosis. radiographic course of. 509 Wind, whole-body exposure in asthmatics to cold and, 1728 Wolff-Parkinson-White syndrome. concertinalike phenomenon in. 937 Work capacity evaluation, work placement and worker fitness. 1564 Work of breathing, changes in. during CPAP, 860

triggering. estimation of. 1836 Workload. revisiting the Ubby Zion case, 977 Wounds, early onset pneumonia in trauma patients.224 interatrial right-to-left shunting after. 1614 Wrist . compression. test of radial arterial pressure during anesthesia, 69

SUlject Index, VoUne 105 (~lnt, 1994)